BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1444023	NCC1(Cc2c(O1)ccc(Cl)c2-c1ccccc1)c1ccccc1	InChI=1S/C21H18ClNO/c22-18-11-12-19-17(20(18)15-7-3-1-4-8-15)13-21(14-23,24-19)16-9-5-2-6-10-16/h1-12H,13-14,23H2	YHAUXPAEVZYOOI-UHFFFAOYSA-N	695243	US12083101, Example 1	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6800							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695243	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695243&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444024	NC[C@@]1(Cc2c(O1)ccc(Cl)c2-c1ccccc1)c1ccccc1 |r|	InChI=1S/C21H18ClNO/c22-18-11-12-19-17(20(18)15-7-3-1-4-8-15)13-21(14-23,24-19)16-9-5-2-6-10-16/h1-12H,13-14,23H2	YHAUXPAEVZYOOI-UHFFFAOYSA-N	695244	US12083101, Example 1a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1220							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695244	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695244&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444025	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1ccccc1)c1ccccc1 |r|	InChI=1S/C21H18ClNO/c22-18-11-12-19-17(20(18)15-7-3-1-4-8-15)13-21(14-23,24-19)16-9-5-2-6-10-16/h1-12H,13-14,23H2	YHAUXPAEVZYOOI-UHFFFAOYSA-N	695245	US12083101, Example 1b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		>100000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695245	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695245&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444026	NCCNc1cccc(F)c1-c1c2C[C@@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wD:14.15,(9.2,2.55,;7.87,1.78,;6.53,2.55,;5.2,1.78,;3.86,2.55,;3.86,4.09,;2.53,4.86,;1.2,4.09,;1.2,2.55,;-.			695246	US12083101, Example 2a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 36.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695246	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695246&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444027	NCCNc1cccc(F)c1-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:14.15,(9.2,2.55,;7.87,1.78,;6.53,2.55,;5.2,1.78,;3.86,2.55,;3.86,4.09,;2.53,4.86,;1.2,4.09,;1.2,2.55,;-.14,1.78,;2.53,1.78,;2.53,.24,;1.2,-.53,;-.27,-.06,;-1.17,-1.3,;-2.32,-.27,;-2,1.23,;-.27,-2.55,;1.2,-2.07,;2.53,-2.84,;3.86,-2.07,;3.86,-.53,;5.2,.24,;-2.32,-2.33,;-2,-3.84,;-3.14,-4.87,;-4.61,-4.39,;-4.93,-2.89,;-3.78,-1.86,)|	InChI=1S/C23H23ClFN3O/c24-17-9-10-20-16(13-23(14-27,29-20)15-5-2-1-3-6-15)21(17)22-18(25)7-4-8-19(22)28-12-11-26/h1-10,28H,11-14,26-27H2	SECHVVKBCVBFLP-UHFFFAOYSA-N	695247	US12083101, Example 2b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 247800							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695247	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695247&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444028	NCCNc1cccc(F)c1-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:14.25,(2.37,-1.55,;1.03,-2.32,;1.03,-3.86,;-.3,-4.63,;-1.63,-3.86,;-1.63,-2.32,;-2.97,-1.55,;-4.3,-2.32,;-4.3,-3.86,;-5.63,-4.63,;-2.97,-4.63,;-2.97,-6.17,;-1.63,-6.94,;-.17,-6.47,;.74,-7.71,;1.82,-8.8,;1.43,-10.29,;-.17,-8.96,;-1.63,-8.48,;-2.97,-9.25,;-4.3,-8.48,;-4.3,-6.94,;-5.63,-6.17,;2.28,-7.71,;3.05,-9.05,;4.59,-9.05,;5.36,-7.71,;4.59,-6.38,;3.05,-6.38,)|	InChI=1S/C23H23ClFN3O/c24-17-9-10-20-16(13-23(14-27,29-20)15-5-2-1-3-6-15)21(17)22-18(25)7-4-8-19(22)28-12-11-26/h1-10,28H,11-14,26-27H2	SECHVVKBCVBFLP-UHFFFAOYSA-N	695248	US12083101, Example 2a-1	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 26.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695248	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695248&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444029	NCCNc1cccc(F)c1-c1c2C[C@@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wD:14.25,(2.37,-1.55,;1.03,-2.32,;1.03,-3.86,;-.3,-4.63,;-1.63,-3.86,;-1.63,-2.32,;-2.97,-1.55,;-4.3,-2.32,;-4.3,-3.86,;-5.63,-4.63,;-2.97,-4.63,;-2.97,-6.17,;-1.63,-6.94,;-.17,-6.47,;.74,-7.71,;1.82,-8.8,;1.43,-10.29,;-.17,-8.96,;-1.63,-8.48,;-2.97,-9.25,;-4.3,-8.48,;-4.3,-6.94,;-5.63,-6.17,;2.28,-7.71,;3.05,-9.05,;4.59,-9.05,;5.36,-7.71,;4.59,-6.38,;3.05,-6.38,)|	InChI=1S/C23H23ClFN3O/c24-17-9-10-20-16(13-23(14-27,29-20)15-5-2-1-3-6-15)21(17)22-18(25)7-4-8-19(22)28-12-11-26/h1-10,28H,11-14,26-27H2	SECHVVKBCVBFLP-UHFFFAOYSA-N	695249	US12083101, Example 2a-2	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1310							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695249	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695249&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444030	NCCOc1cccc(F)c1-c1c2C[C@@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wD:14.25,(2.37,-1.55,;1.03,-2.32,;1.03,-3.86,;-.3,-4.63,;-1.63,-3.86,;-1.63,-2.32,;-2.97,-1.55,;-4.3,-2.32,;-4.3,-3.86,;-5.63,-4.63,;-2.97,-4.63,;-2.97,-6.17,;-1.63,-6.94,;-.17,-6.47,;.74,-7.71,;1.82,-8.8,;1.43,-10.29,;-.17,-8.96,;-1.63,-8.48,;-2.97,-9.25,;-4.3,-8.48,;-4.3,-6.94,;-5.63,-6.17,;2.28,-7.71,;3.05,-9.05,;4.59,-9.05,;5.36,-7.71,;4.59,			695250	US12083101, Example 3a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 16.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695250	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695250&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444031	NCCOc1cccc(F)c1-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:14.25,(2.37,-1.55,;1.03,-2.32,;1.03,-3.86,;-.3,-4.63,;-1.63,-3.86,;-1.63,-2.32,;-2.97,-1.55,;-4.3,-2.32,;			695251	US12083101, Example 3b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 18000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695251	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695251&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444032	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:2.24,(1.57,2.15,;1.97,3.64,;.88,4.73,;-.02,5.98,;-1.49,5.5,;-1.49,3.96,;-.02,3.48,;-2.82,3.19,;-4.15,3.96,;-4.15,5.5,;-5.49,6.27,;-2.82,6.27,;-2.82,7.81,;-4.15,8.58,;-5.49,7.81,;-4.15,10.12,;-2.82,10.89,;-1.49,10.12,;-1.49,8.58,;-.15,7.81,;1.18,8.58,;.62,6.48,;2.42,4.73,;3.19,3.4,;4.73,3.4,;5.5,4.73,;4.73,6.06,;3.19,6.06,)|	InChI=1S/C22H18ClFN2O2/c23-16-9-10-18-15(11-22(12-25,28-18)13-5-2-1-3-6-13)19(16)20-14(21(26)27)7-4-8-17(20)24/h1-10H,11-12,25H2,(H2,26,27)	YCTAOJHXCMLYDB-UHFFFAOYSA-N	695252	US12083101, Example 4a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 34.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695252&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444033	NC[C@@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wD:2.24,(1.57,2.15,;1.97,3.64,;.88,4.73,;-.02,5.98,;-1.49,5.5,;-1.49,3.96,;-.02,3.48,;-2.82,3.19,;-4.15,3.96,;-4.15,5.5,;-5.49,6.27,;-2.82,6.27,;-2.82,7.81,;-4.15,8.58,;-5.49,7.81,;-4			695253	US12083101, Example 4b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		>100000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695253&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444034	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:15.26,(-6.15,10.35,;-4.82,11.12,;-3.49,10.35,;-2.15,11.12,;-.82,10.35,;-.82,8.81,;.51,8.04,;1.85,8.81,;1.28,6.71,;-2.15,8.04,;-3.49,8.81,;-4.82,8.04,;-2.15,6.5,;-.82,5.73,;.65,6.21,;1.55,4.96,;2.64,3.87,;2.24,2.38,;.65,3.71,;-.82,4.19,;-2.15,3.42,;-3.49,4.19,;-3.49,5.73,;-4.82,6.5,;3.09,4.96,;3.86,3.63,;5.4,3.63,;6.17,4.96,;5.4,6.29,;3.86,6.29,)|	InChI=1S/C23H20ClFN2O3/c1-29-18-9-7-14(22(27)28)20(21(18)25)19-15-11-23(12-26,13-5-3-2-4-6-13)30-17(15)10-8-16(19)24/h2-10H,11-12,26H2,1H3,(H2,27,28)	SOKTXWCWAHTAPT-UHFFFAOYSA-N	695254	US12083101, Example 5a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695254&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444035	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wD:15.26,(-6.15,10.35,;-4.82,11.12,;-3.49,10.35,;-2.15,11.12,;-.82,10.35,;-.82,8.81,;.51,8.04,;1.85,8.81,;1.28,6.71,;-2.15,8.04,;-3.49,8.81,;-4.82,8.04,;-2.15,6.5,;-.82,5.73,;.65,6.21,;1.55,4.96,;2.64,3.87,;2.24,2.38,;.65,3.71,;-.82,4.19,;-2.15,3.42,;-3.49,4.19,;-3.49,5.73,;-4.82,6.5,;3.09,4.96,;3.86,3.63,;5.4,3.63,;6.17,4.96,;5.4,6.29,;3.86,6.29,)|	InChI=1S/C23H20ClFN2O3/c1-29-18-9-7-14(22(27)28)20(21(18)25)19-15-11-23(12-26,13-5-3-2-4-6-13)30-17(15)10-8-16(19)24/h2-10H,11-12,26H2,1H3,(H2,27,28)	SOKTXWCWAHTAPT-UHFFFAOYSA-N	695255	US12083101, Example 5b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 23300							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695255&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444036	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:2.24,(1.57,-4.37,;1.96,-2.88,;.88,-1.79,;-.03,-.55,;-1.49,-1.02,;-1.49,-2.56,;-.03,-3.04,;-2.83,-3.33,;-4.16,-2.56,;-4.16,-1.02,;-5.5,-.25,;-2.83,-.25,;-2.83,1.29,;-4.16,2.06,;-5.5,1.29,;-4.16,3.6,;-2.83,4.37,;-1.49,3.6,;-1.49,2.06,;-.16,1.29,;1.17,2.06,;.61,-.05,;2.42,-1.79,;3.19,-3.13,;4.73,-3.13,;5.5,-1.79,;4.73,-.46,;3.19,-.46,)|	InChI=1S/C22H18ClFN2O2/c23-16-9-10-18-15(11-22(12-25,28-18)13-5-2-1-3-6-13)19(16)20-14(21(26)27)7-4-8-17(20)24/h1-10H,11-12,25H2,(H2,26,27)	YCTAOJHXCMLYDB-UHFFFAOYSA-N	695256	US12083101, Example 4a-1	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 20.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695256&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444037	Cc1cccc(C(N)=O)c1-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:13.24,(-5.5,1.29,;-4.16			695257	US12083101, Example 6	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 376							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695257&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444038	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(Cl)cccc1C(N)=O)c1ccccc1 |r,wU:2.24,(1.57,-4.37,;1.96,-2.88,;.88,-1.79,;-.03,-.55,;-1.49,-1.02,;-1.49,-2.56,;-.03,-3.04,;-2.83,-3.33,;-4.16,-2.56,;-4.16,-1.02,;-5.5,-.25,;-2.83,-.25,;-2.83,1.29,;-4.16,2.06,;-5.5,1.29,;-4.16,3.6,;-2.83,4.37,;-1.49,3.6,;-1.49,2.06,;-.16,1.29,;1.17,2.06,;.61,-			695258	US12083101, Example 7	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 65.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695258&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444039	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(Cl)ccc1C(N)=O)c1ccccc1 |r,wU:2.25,(1.57,-4.37,;1.96,-2.88,;.88,-1.79,;-.03,-.55,;-1.49,-1.02,;-1.49,-2.56,;-.03,-3.04,;-2.83,-3.33,;-4.16,-2.56,;-4.16,-1.02,;-5.5,-.25,;-2.83,-.25,;-2.83,1.29,;-4.16,2.06,;-			695259	US12083101, Example 8	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695259&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444040	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(F)ccc1C(N)=O)c1ccccc1 |r,wU:2.25,(1.57,-4.37,;1.96,-2.88,;.88,-1.79,;-.03,-.55,;-1.49,-1.02,;-1.49,-2.56,;-.03,-3.04,;-2.83,-3.33,;-4.16,-2.56,;-4.16,-1.02,;-5.5,-.25,;-2.83,-.25,;-2.83,1.29,;-4.16,2.06,;-5.5,1.29,;-4.16,3.6,;-5.5,4.37,;-2.83,4.37,;-1.49,3.6,;-1.49,2.06,;-.16,1.29,;1.17,2.06,;.61,-.05,;2.42,-1.79,;3.19,-3.13,;4.73,-3.13,;5.5,-1.79,;4.73,-.46,;3.19,-.46,)|	InChI=1S/C22H17ClF2N2O2/c23-15-7-9-17-14(10-22(11-26,29-17)12-4-2-1-3-5-12)18(15)19-13(21(27)28)6-8-16(24)20(19)25/h1-9H,10-11,26H2,(H2,27,28)	OSTZRIKTMIQNIE-UHFFFAOYSA-N	695260	US12083101, Example 9	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695260&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444041	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:2.28,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-.55,;.51,-1.02,;.51,-2.56,;1.97,-3.04,;-.83,-3.33,;-2.16,-2.56,;-2.16,-1.02,;-3.49,-.25,;-.83,-.25,;-.83,1.29,;-2.16,2.06,;-3.49,1.29,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-6.16,4.37,;-7.5,3.6,;-.83,4.37,;.51,3.6,;.51,2.06,;1.84,1.29,;3.17,2.06,;2.61,-.05,;4.42,-1.79,;5.19,-3.13,;6.73,-3.13,;7.5,-1.79,;6.73,-.46,;5.19,-.46,)|	InChI=1S/C24H22ClFN2O4/c25-17-7-9-18-16(12-24(13-27,32-18)14-4-2-1-3-5-14)20(17)21-15(23(28)30)6-8-19(22(21)26)31-11-10-29/h1-9,29H,10-13,27H2,(H2,28,30)	CXZFQTJAXWOQAP-UHFFFAOYSA-N	695261	US12083101, Example 10	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695261&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444042	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:2.28,(2.9,-4.37,;3.3,-2.88,;2.21,-1.79,;1.3,-.55,;-.16,-1.02,;-.16,-2.56,;1.3,-3.04,;-1.49,-3.33,;-2.83,-2.56,;-2.83,-1.02,;-4.16,-.25,;-1.49,-.25,;-1.49,1.29,;-2.83,2.06,;-			695262	US12083101, Example 11	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 21.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695262	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695262&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444043	COCCOc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.29,(-8.16,4.37,;-6.83,3.6,;-5.5,4.37,;-4.16,3.6,;-2.83,4.37,;-1.49,3.6,;-.16,4.37,;1.17,3.6,;1.17,2.06,;2.51,1.29,;3.84,2.06,;3.28,-.05,;-.16,1.29,;-1.49,2.06,;-2.83,1.29,;-.16,-.25,;1.17,-1.02,;2.64,-.55,;3.54,-1.79,;4.63,-2.88,;4.23,-4.37,;2.64,-3.04,			695263	US12083101, Example 12	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.50							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695263	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695263&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444044	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.29,wD:1.1,(-7.5,2.83,;-6.16,3.6,;-6.16,5.14,;-4.83,2.83,;-3.49,3.6,;-2.16,2.83,;-.83,3.6,;.51,2.83,;.51,1.29,;1.84,.52,;3.17,1.29,;2.61,-.82,;-.83,.52,;-2.16,1.29,;-3.49,.52,;-.83,-1.02,;.51,-1.79,;1.97,-1.32,;2.88,-2.56,;3.96,-3.65,;3.57,-5.14,;1.97,-3.81,;.51,-3.33,;-.83,-4.1,;-2.16,-3.33,;-2.16,-1.79,;-3.49,-1.02,;4.42,-2.			695264	US12083101, Example 13	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695264	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695264&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444045	C[C@@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.29,1.1,(-7.5,2.83,;-6.16,3.6,;-6.16,5.14,;-4.83,2.83,;-3.49,3.6,;-2.16,2.83,;-.83,3.6,;.51,2.83,;.51,1.29,;1.84,.52,;3.17,1.29,;2.61,-.82,;-.83,.52,;-2.16,1.29,;-3.49,.52,;-.83,-1.02,;.51,-1.79,;1.97,-1.32,;2.88,-2.56,;3.96,-3.65,;3.57,-5.14,;1.97,-3.81,;.51,-3.33,;-.83,-4.1,;-2.16,-3.33,;-2.16,-1.79,;-3.49,-1.02,;4.42,-2.56,;5.19,-3.9,;6.73,-3.9,;7.5,-2.56,;6.73,-1.23,;5.19,-1.23,)|	InChI=1S/C25H24ClFN2O4/c1-14(30)12-32-20-9-7-16(24(29)31)22(23(20)27)21-17-11-25(13-28,15-5-3-2-4-6-15)33-19(17)10-8-18(21)26/h2-10,14,30H,11-13,28H2,1H3,(H2,29,31)	HDNUILLJVJBXSL-UHFFFAOYSA-N	695265	US12083101, Example 14	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 15.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695265	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695265&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444046	C[C@@H](F)COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.29,wD:1.1,(-6.16,5.14,;-6.16,3.6,;-7.5,2.83,;-4.83,2.83,;-3.49,3.6,;-2.16,2.83,;-.83,3.6,;.51,2.83,;.51,1.29,;1.84,.52,;3.17,1.29,;2.61,-.82,;-.83,.52,;-2.16,1.29,;-3.49,.52,;-.83,-1.02,;.51,-1.79,;1.97,-1.32,;2.88,-2.56,;3.96,-3.65,;3.57,-5.14,;1.97,-3.81,;.51,-3.33,;-.83,-4.1,;-2.16,-3.33,;-2.16,-1.79,;-3.49,-1.02,;4.42,-2.56,;5.19,-3.9,;6.73,-3.9,;7.5,-2.56,;6.73,-1.23,;5.19,-1.23,)|	InChI=1S/C25H23ClF2N2O3/c1-14(27)12-32-20-9-7-16(24(30)31)22(23(20)28)21-17-11-25(13-29,15-5-3-2-4-6-15)33-19(17)10-8-18(21)26/h2-10,14H,11-13,29H2,1H3,(H2,30,31)	BIDVSIYYLGXOMZ-UHFFFAOYSA-N	695266	US12083101, Example 15	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695266&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444047	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OCC(O)=O)ccc1C(N)=O)c1ccccc1 |r,wU:2.29,(3.57,-5.14,;3.96,-3.65,;2.88,-2.56,;1.97,-1.32,;.51,-1.79,;.51,-3.33,;1.97,-3.81,;-.83,-4.1,;-2.16,-3.33,;-2.16,-1.79,;-3.49,-1.02,;-.83,-1.02,;-.83,.52,;-2.16,1.29,;-3.49,.52,;-2.16,2.83,;-3.49,3.6,;-4.83,2.83,;-6.16,3.6,;-7.5,2.83,;-6.16,5.14,;-.83,3.6,;.51,2.83,;.51,1.29,;1.84,.52,;3.17,1.29,;2.61,-.82,;4.42,-2.56,;5.19,-3.9,;6.73,-3.9,;7.5,-2.56,;6.73,-1.23,;5.19,-1.23,)|	InChI=1S/C24H20ClFN2O5/c25-16-7-9-17-15(10-24(12-27,33-17)13-4-2-1-3-5-13)20(16)21-14(23(28)31)6-8-18(22(21)26)32-11-19(29)30/h1-9H,10-12,27H2,(H2,28,31)(H,29,30)	VPZUSHMYZGRBGV-UHFFFAOYSA-N	695267	US12083101, Example 16	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695267&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444048	CC(=O)N1CCO[C@@H](COc2ccc(C(N)=O)c(c2F)-c2c3C[C@](CN)(Oc3ccc2Cl)c2ccccc2)C1 |r,wU:23.34,wD:7.7,(-5.5,6.68,;-6.83,5.91,;-8.16,6.68,;-6.83,4.37,;-8.16,3.6,;-8.16,2.06,;-6.83,1.29,;-5.5,2.06,;-4.16,1.29,;-2.83,2.06,;-1.49,1.29,;-.16,2.06,;1.17,1.29,;1.17,-.25,;2.51,-1.02,;3.84,-.25,;3.28,-2.36,;-.16,-1.02,;-1.49,-.25,;-2.83,-1.02,;-.16,-2.56,;1.17,-3.33,;2.64,-2.86,;3.54,-4.1,;4.63,-5.19,;4.23,-6.68,;2.64,-5.35,;1.17,-4.87,;-.16,-5.64,;-1.49,-4.87,;-1.49,-3.33,;-2.83,-2.56,;5.08,-4.1,;5.85,-5.44,;7.39,-5.44,;8.16,-4.1,;7.39,-2.77,;5.85,-2.77,;-5.5,3.6,)|	InChI=1S/C29H29ClFN3O5/c1-17(35)34-11-12-37-19(14-34)15-38-24-9-7-20(28(33)36)26(27(24)31)25-21-13-29(16-32,18-5-3-2-4-6-18)39-23(21)10-8-22(25)30/h2-10,19H,11-16,32H2,1H3,(H2,33,36)	JFCVYDDZSJFBAS-UHFFFAOYSA-N	695268	US12083101, Example 17	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 13.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695268	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695268&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444049	COc1ncc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |wU:15.26,(-1.33,-6.93,;-1.33,-5.39,;,-4.62,;1.33,-5.39,;2.67,-4.62,;2.67,-3.08,;4,-2.31,;4,-.77,;5.33,-3.08,;1.33,-2.31,;,-3.08,;-1.33,-2.31,;1.33,-.77,;;-1.46,-.48,;-2.37,.77,;-3.51,-.26,;-3.19,-1.77,;-1.46,2.02,;,1.54,;1.33,2.31,;2.67,1.54,;2.67,,;4.2,.16,;-3.51,1.8,;-4.98,1.32,;-6.12,2.35,;-5.8,3.86,;-4.34,4.34,;-3.19,3.31,)|	InChI=1S/C22H19ClFN3O3/c1-29-21-19(24)18(14(10-27-21)20(26)28)17-13-9-22(11-25,12-5-3-2-4-6-12)30-16(13)8-7-15(17)23/h2-8,10H,9,11,25H2,1H3,(H2,26,28)	WIMYACTZLWLCDT-UHFFFAOYSA-N	695269	US12083101, Example 18::4-((2S,4S)-2-(Aminomethyl)-5-chloro-2-phenyl-2,3-dihydrobenzofuran-4-yl)-5- fluoro-6-methoxynicotinamide	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695269&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444050	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OC(F)F)ncc1C(N)=O)c1ccccc1 |r,wU:2.28,(2.9,-4.37,;3.3,-2.88,;2.21,-1.79,;1.3,-.55,;-.16,-1.02,;-.16,-2.56,;1.3,-3.04,;-1.49,-3.33,;-2.83,-2.56,;-2.83,-1.02,;-4.16,-.25,;-1.49,-.25,;-1.49,1.29,;-2.83,2.06,;-4.16,1.29,;-2.83,3.6,;-4.16,4.37,;-5.5,3.6,;-6.83,4.37,;-5.5,2.06,;-1.49,4.37,;-.16,3.6,;-.16,2.06,;1.17,1.29,;2.51,2.06,;1.94,-.05,;3.75,-1.79,;4.52,-3.13,;6.06,-3.13,;6.83,-1.79,;6.06,-.46,;4.52,-.46,)|	InChI=1S/C22H17ClF3N3O3/c23-14-6-7-15-12(8-22(10-27,32-15)11-4-2-1-3-5-11)16(14)17-13(19(28)30)9-29-20(18(17)24)31-21(25)26/h1-7,9,21H,8,10,27H2,(H2,28,30)	CLWQJZGFFNHWRX-UHFFFAOYSA-N	695270	US12083101, Example 19	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695270	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695270&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444051	CNc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:15.26,(-6.16,3.6,;-4.83,4.37,;-3.49,3.6,;-2.16,4.37,;-.83,3.6,;-.83,2.06,;.51,1.29,;1.84,2.06,;1.28			695271	US12083101, Example 20	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 124							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695271	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695271&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444052	CNC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OC)ccc1C(N)=O)c1ccccc1 |r,wU:3.27,(3.57,-4.75,;2.23,-3.98,;2.63,-2.5,;1.54,-1.41,;.64,-.16,;-.83,-.64,;-.83,-2.18,;.64,-2.65,;-2.16,-2.95,;-3.49,-2.18,;-3.49,-.64,;-4.83,.13,;-2.16,.13,;-2.16,1.67,;-3.49,2.44,;-4.83,1.67,;-3.49,3.98,;-4.83,4.75,;-6.16,3.98,;-2.16,4.75,;-.83,3.98,;-.83,2.44,;.51,1.67,;1.84,2.44,;1.28,.34,;3.08,-1.41,;3.85,-2.74,;5.39,-2.74,;6.16,-1.41,;5.39,-.07,;3.85,-.07,)|	InChI=1S/C24H22ClFN2O3/c1-28-13-24(14-6-4-3-5-7-14)12-16-18(31-24)11-9-17(25)20(16)21-15(23(27)29)8-10-19(30-2)22(21)26/h3-11,28H,12-13H2,1-2H3,(H2,27,29)	GWSJFPPKTOKOCC-UHFFFAOYSA-N	695272	US12083101, Example 21	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695272	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695272&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444053	CNC(=O)c1ccc(OC)c(F)c1-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:16.27,(3.17,1.29,;			695273	US12083101, Example 22	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 9.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695273	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695273&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444054	COc1ccc(C(=O)NC2CC2)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.30,(-6.16,3.6,;-4.83,4.37,;-3.49,3.6,;-2.16,4.37,;-.83,3.6,;-.83,2.06,;.51,1.29,;1.28,-.05,			695274	US12083101, Example 23	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 9.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695274	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695274&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444055	Cn1nccc1NC(=O)c1ccc(F)c(F)c1-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:20.32,(3.22,4.58,;3.62,3.09,;5.08,2.62,;5.08,1.08,;3.62,.6,;2.71,1.85,;1.17,1.85,;-.16,1.08,;.61,-.26,;-1.49,1.85,;-1.49,3.39,;-2.83,4.16,;-4.16,3.39,;-5.5,4.16,;-4.16,1.85,;-5.5,1.08,;-2.83,1.08,;-2.83,-.46,;-1.49,-1.23,;-.03,-.76,;.88,-2,;1.96,-3.09,;1.57,-4.58,;-.03,-3.25,;-1.49,-2.77,;-2.83,-3.54,;-4.16,-2.77,;-4.16,-1.23,;-5.5,-.46,;2.42,-2,;3.19,-3.34,;4.73,-3.34,;5.5,-2,;4.73,-.67,;3.19,-.67,)|	InChI=1S/C26H21ClF2N4O2/c1-33-21(11-12-31-33)32-25(34)16-7-9-19(28)24(29)23(16)22-17-13-26(14-30,15-5-3-2-4-6-15)35-20(17)10-8-18(22)27/h2-12H,13-14,30H2,1H3,(H,32,34)	CRORDNJHJWLYKR-UHFFFAOYSA-N	695275	US12083101, Example 24	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695275	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695275&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444056	COc1ccc(C(=O)Nc2cccnc2)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:21.33,(-6.31,3.6,;-4.98,4.37,;-3.64,3.6,;-2.31,4.37,;-.98,3.6,;-.98,2.06,;.36,1.29,;1.13,-.05,;1.69,2.06,;3.23,2.06,;4,.72,;5.54,.72,;6.31,2.06,;5.54,3.39,;4,3.39,;-2.31,1.29,;-3.64,2.06,;-4.98,1.29,;-2.31,-.25,;-.98,-1.02,;.49,-.55,;1.39,-1.79,;2.48,-2.88,;2.08,-4.37,;.49,-3.04,;-.98,-2.56,;-2.31,-3.33,;-3.64,-2.56,;-3.64,-1.02,;-4.98,-.25,;2.93,-1.79,;3.7,-3.13,;5.24,-3.13,;6.01,-1.79,;5.24,-.46,;3.7,-.46,)|	InChI=1S/C28H23ClFN3O3/c1-35-23-11-9-19(27(34)33-18-8-5-13-32-15-18)25(26(23)30)24-20-14-28(16-31,17-6-3-2-4-7-17)36-22(20)12-10-21(24)29/h2-13,15H,14,16,31H2,1H3,(H,33,34)	WWDSEBFEXGFCCV-UHFFFAOYSA-N	695276	US12083101, Example 25	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695276	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695276&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444057	CNC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OC)ccc1C(=O)NC)c1ccccc1 |r,wU:3.28,(3.57,-4.75,;2.23,-3.98,;2.63,-2.5,;1.54,-1.41,;.64,-.16,;-.83,-.64,;-.83,-2.18,;.64,-2.65,;-2.16,-2.95,;-3.49,-2.18,;-3.49,-.64,;-4.83,.13,;-2.16,.13,;-2.16,1.67,;-3.49,2.44,;-4.83,1.67,;-3.49,3.98,;-4.83,4.75,;-6.16,3.98,;-2.16,4.75,;-.83,3.98,;-.83,2.44,;.51,1.67,;1.28,.34,;1.84,2.44,;3.17,1.67,;3.08,-1.41,;3.85,-.07,;5.39,-.07,;6.16,-1.41,;5.39,-2.74,;3.85,-2.74,)|	InChI=1S/C25H24ClFN2O3/c1-28-14-25(15-7-5-4-6-8-15)13-17-19(32-25)12-10-18(26)21(17)22-16(24(30)29-2)9-11-20(31-3)23(22)27/h4-12,28H,13-14H2,1-3H3,(H,29,30)	ABENQGVCKGCDHF-UHFFFAOYSA-N	695277	US12083101, Example 26	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 21.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695277	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695277&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444058	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@H](O)CC3)(Oc2ccc1Cl)c1ccccc1 |r,wU:15.34,18.18,wD:21.22,(-6.37,14.67,;-5.03,15.44,;-3.7,14.67,;-2.37,15.44,;-1.03,14.67,;-1.03,13.13,;.3,12.36,;1.64,13.13,;1.07,11.02,;-2.37,12.36,;-3.7,13.13,;-5.03,12.36,;-2.37,10.82,;-1.03,10.05,;.43,10.52,;1.34,9.28,;2.43,8.19,;2.03,6.7,;3.12,5.61,;4.6,6.01,;5.69,4.92,;5.29,3.43,;6.38,2.34,;3.81,3.03,;2.72,4.12,;.43,8.03,;-1.03,8.51,;-2.37,7.74,;-3.7,8.51,;-3.7,10.05,;-5.03,10.82,;2.88,9.28,;3.65,10.61,;5.19,10.61,;5.96,9.28,;5.19,7.94,;3.65,7.94,)|	InChI=1S/C29H30ClFN2O4/c1-36-24-13-11-20(28(32)35)26(27(24)31)25-21-15-29(17-5-3-2-4-6-17,37-23(21)14-12-22(25)30)16-33-18-7-9-19(34)10-8-18/h2-6,11-14,18-19,33-34H,7-10,15-16H2,1H3,(H2,32,35)	AGNATXZDYARICH-UHFFFAOYSA-N	695278	US12083101, Example 27a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695278	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695278&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444059	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@@H]3CC[C@H](O)CC3)(Oc2ccc1Cl)c1ccccc1 |r,wU:15.34,18.18,21.22,(-6.37,14.67,;-5.03,15.44,;-3.7,14.67,;-2.37,15.44,;-1.03,14.67,;-1.03,13.13,;.3,12.36,;1.64,13.13,;1.07,11.02,;-2.37,12.36,;-3.7,13.13,;-5.03,12.36,;-2.37,10.82,;-1.03,10.05,;.43,10.52,;1.34,9.28,;2.43,8.19,;2.03,6.7,;3.12,5.61,;2.72,4.12,;3.81,3.03,;5.29,3.43,;6.38,2.34,;5.69,4.92,;4.6,6.01,;.43,8.03,;-1.03,8.51,;-2.37,7.74,;-3.7,8.51,;-3.7,10.05,;-5.03,10.82,;2.88,9.28,;3.65,10.61,;5.19,10.61,;5.96,9.28,;5.19,7.94,;3.65,7.94,)|	InChI=1S/C29H30ClFN2O4/c1-36-24-13-11-20(28(32)35)26(27(24)31)25-21-15-29(17-5-3-2-4-6-17,37-23(21)14-12-22(25)30)16-33-18-7-9-19(34)10-8-18/h2-6,11-14,18-19,33-34H,7-10,15-16H2,1H3,(H2,32,35)	AGNATXZDYARICH-UHFFFAOYSA-N	695279	US12083101, Example 27b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695279	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695279&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444060	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@@H](CC3)C(O)=O)(Oc2ccc1Cl)c1ccccc1 |r,wU:15.36,18.18,wD:21.25,(-7.85,15.21,;-6.52,15.98,;-5.19,15.21,;-3.85,15.98,;-2.52,15.21,;-2.52,13.67,;-1.18,12.9,;.15,13.67,;-1.18,11.36,;-3.85,12.9,;-5.19,13.67,;-6.52,12.9,;-3.85,10.96,;-2.52,10.19,;-1.05,10.66,;-.15,9.42,;1.18,8.65,;1.18,7.11,;2.52,6.34,;3.85,7.11,;5.19,6.34,;5.19,4.8,;3.85,4.03,;2.52,4.8,;6.52,4.03,;7.85,4.8,;6.52,2.49,;-1.05,8.17,;-2.52,8.65,;-3.85,7.88,;-5.19,8.65,;-5.19,10.19,;-6.52,10.96,;1.18,10.19,;2.52,9.42,;3.85,10.19,;3.85,11.73,;2.52,12.5,;1.18,11.73,)|	InChI=1S/C30H30ClFN2O5/c1-38-24-13-11-20(28(33)35)26(27(24)32)25-21-15-30(18-5-3-2-4-6-18,39-23(21)14-12-22(25)31)16-34-19-9-7-17(8-10-19)29(36)37/h2-6,11-14,17,19,34H,7-10,15-16H2,1H3,(H2,33,35)(H,36,37)	UGYBFYLZPNXUIR-UHFFFAOYSA-N	695280	US12083101, Example 28a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695280	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695280&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444061	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@H](CC3)C(O)=O)(Oc2ccc1Cl)c1ccccc1 |r,wU:15.36,18.18,21.25,(-7.85,15.21,;-6.52,15.98,;-5.19,15.21,;-3.85,15.98,;-2.52,15.21,;-2.52,13.67,;-1.18,12.9,;.15,13.67,;-1.18,11.36,;-3.85,12.9,;-5.19,13.67,;-6.52,12.9,;-3.85,10.96,;-2.52,10.19,;-1.05,10.66,;-.15,9.42,;1.18,8.65,;1.18,7.11,;2.52,6.34,;3.85,7.11,;5.19,6.34,;5.19,4.8,;3.85,4.03,;2.52,4.8,;6.52,4.03,;7.85,4.8,;6.52,2.49,;-1.05,8.17,;-2.52,8.65,;-3.85,7.88,;-5.19,8.65,;-5.19,10.19,;-6.52,10.96,;1.18,10.19,;2.52,9.42,;3.85,10.19,;3.85,11.73,;2.52,12.5,;1.18,11.73,)|	InChI=1S/C30H30ClFN2O5/c1-38-24-13-11-20(28(33)35)26(27(24)32)25-21-15-30(18-5-3-2-4-6-18,39-23(21)14-12-22(25)31)16-34-19-9-7-17(8-10-19)29(36)37/h2-6,11-14,17,19,34H,7-10,15-16H2,1H3,(H2,33,35)(H,36,37)	UGYBFYLZPNXUIR-UHFFFAOYSA-N	695281	US12083101, Example 28b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695281	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695281&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444062	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1cscn1 |r,wU:15.26,(-5.81,3.6,;-4.47,4.37,;-3.14,3.6,;-1.81,4.37,;-.47,3.6,;-.47,2.06,;.86,1.29,;2.19,2.06,;1.63,-.05,;-1.81,1.29,;-3.14,2.06,;-4.47,1.29,;-1.81,-.25,;-.47,-1.02,;.99,-.55,;1.9,-1.79,;2.99,-2.88,;2.59,-4.37,;.99,-3.04,;-.47,-2.56,;-1.81,-3.33,;-3.14,-2.56,;			695282	US12083101, Example 29	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695282	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695282&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444063	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1cccc2OC(F)(F)Oc12 |r,wU:2.24,(1.57,-3.06,;1.96,-1.57,;.88,-.48,;-.03,.76,;-1.49,.29,;-1.49,-1.25,;-.03,-1.73,;-2.83,-2.02,;-4.16,-1.25,;-4.16,.29,;-5.5,1.06,;-2.83,1.06,;-2.83,2.6,;-4.16,3.37,;-			695283	US12083101, Example 30	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 143							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695283	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695283&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444064	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2ccc1Cl)c1ccccc1F |r,wU:15.26,(-6.16,3.64,;-4.83,4.41,;-3.49,3.64,;-2.16,4.41,;-.83,3.64,;-.83,2.1,;.51,1.33,;1.84,2.1,;1.28,,;-2.16,1.33,;-3.49,2.1,;-4.83,1.33,;-2.16,-.21,;-.83,-.98,;.64,-.5,;1.54,-1.75,;2.63,-2.84,;2.23,-4.32,;.64,-2.99,;-.83,-2.52,;-2.16,-3.29,;-3.49,-2.52,;-3.49,-.98,;-4.83,-.21,;3.08,-1.75,;3.85,-.41,;5.39,-.41,;6.16,-1.75,;5.39,-3.08,;3			695284	US12083101, Example 31	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695284	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695284&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444065	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:2.25,(1.57,1.58,;1.97,3.07,;.88,4.16,;-.02,5.41,;-1.49,4.93,;-1.49,3.39,;-.02,2.92,;-2.82,2.62,;-4.15,3.39,;-5.49,2.62,;-4.15,4.93,;-5.49,5.7,;-2.82,5.7,;-2.82,7.24,;-4.15,8.01,;-5.49,7.24,;-4.15,9.55,;-2.82,10.32,;-1.49,9.55,;-1.49,8.01,;-.15,7.24,;1.18,8.01,;.62,5.91,;2.42,4.16,;3.19,5.49,;4.73,5.49,;5.5,4.16,;4.73,2.83,;3.19,2.83,)|	InChI=1S/C22H17ClF2N2O2/c23-20-16(25)9-17-14(10-22(11-26,29-17)12-5-2-1-3-6-12)19(20)18-13(21(27)28)7-4-8-15(18)24/h1-9H,10-11,26H2,(H2,27,28)	WOTUDHGIJXFHBK-UHFFFAOYSA-N	695285	US12083101, Example 32a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 33.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695285	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695285&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444066	NC[C@@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wD:2.25,(1.57,1.58,;1.97,3.07,;.88,4.16,;-.02,5.41,;-1.49,4.93,;-1.49,3.39,;-.02,2.92,;-2.82,2.62,;-			695286	US12083101, Example 32b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		>100000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695286	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695286&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444067	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:15.27,(-6.16,3.6,;-4.83,4.37,;-3.49,3.6,;-2.16,4.37,;-.83,3.6,;-.83,2.06,;.51,1.29,;1.84,2.06,;1.28,-.05,;-2.16,1.29,;-3.49,2.06,;-4.83,1.29,;-2.16,-.25,;-.83,-1.02,;.64,-.55,;1.54,-1.79,;2.63,-2.88,;2.23,-4.37,;.64,-3.04,;-.83,-2.56,;-2.16,-3.33,;-3.49,-2			695287	US12083101, Example 33	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695287	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695287&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444068	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCC2CC2)ccc1C(N)=O)c1ccccc1 |r,wU:2.31,(3.67,-5.04,;4.07,-3.55,;2.98,-2.46,;2.07,-1.21,;.61,-1.69,;.61,-3.23,;2.07,-3.7,;-.72,-4,;-2.06,-3.23,;-3.39,-4,;-2.06,-1.69,;-3.39,-.92,;-.72,-.92,;-.72,.62,;-2.06,1.39,;-3.39,.62,;-2.06,2.93,;-3.39,3.7,;-4.73,2.93,;-6.06,3.7,;-6.83,5.04,;-7.6,3.7,;-.72,3.7,;.61,2.93,;.61,1.39,;1.94,.62,;3.28,1.39,;2.71,-.71,;4.52,-2.46,;5.29,-3.79,;6.83,-3.79,;7.6,-2.46,;6.83,-1.12,;5.29,-1.12,)|	InChI=1S/C26H23ClF2N2O3/c27-23-18(28)10-20-17(11-26(13-30,34-20)15-4-2-1-3-5-15)21(23)22-16(25(31)32)8-9-19(24(22)29)33-12-14-6-7-14/h1-5,8-10,14H,6-7,11-13,30H2,(H2,31,32)	UZHSILROMKMCKC-UHFFFAOYSA-N	695288	US12083101, Example 34	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 9.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695288	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695288&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444069	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:2.29,(2.9,-4.37,;3.3,-2.88,;2.21,-1.79,;1.3,-.55,;-.16,-1.02,;-.16,-2.56,;1.3,-3.04,;-1.49,-3.33,;-2.83,-2.56,;-4.16,-3.33,;-2.83,-1.02,;-4.16,-.25,;-1.49,-.25,;-1.49,1.29,;-2.83,2.06,;-4.16,1.29,;-2.83,3.6,;-4.16,4.37,;-5.5,3.6,;-6.83,4.37,;-5.5,2.06,;-1.49,4.37,;-.16,3.6,;-.16,2.06,;1.17,1.29,;2.51,2.06,;1.94,-.05,;3.75,-1.79,			695289	US12083101, Example 35	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 9.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695289	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695289&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444070	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)(F)CO)ccc1C(N)=O)c1ccccc1 |r,wU:2.31,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-.55,;.51,-1.02,;.51,-2.56,;1.97,-3.04,;-.83,-3.33,;-2.16,-2.56,;-3.49,-3.33,;-2.16,-1.02,;-3.49,-.25,;-.83,-.25,;-.83,1.29,;-2.16,2.06,;-3.49,1.29,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-4.83,2.06,;-6.16,2.83,;-6.16,4.37,;-7.5,3.6,;-.83,4.37,;.51,3.6,;.51,2.06,;1.84,1.29,;3.17,2.06,;2.61,-.05,;4.42,-1.79,;5.19,-3.13,;6.73,-3.13,;7.5,-1.79,;6.73,-.46,;5.19,-.46			695290	US12083101, Example 36	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695290	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695290&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444071	COCCOc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.30,(-8.16,4.37,;-6.83,3.6,;-5.5,4.37,;-4.16,3.6,;-2.83,4.37,;-1.49,3.6,;-.16,4.37,;1.17,3.6,;1.17,2.06,;2.51,1.29,;3.84,2.06,;3.28,-.05,;-.16,1.29,;-1.49,2.06,;-2.83,1.29,;-.16,-.25,;1.17,-1.02,;2.64,-.55,;3.54,-1.79,;4.63,-2.88,;4.23,-4.37,;2.64,-3.04,;1.17,-2.56,;-.16,-3.33,;-1.49,-2.56,;-2.83,-3.33,;-1.49,-1.02,;-2.83,-.25,;5.08,-1.79,;5.85,-3.13,;7.39,-3.13,;8.16,-1.79,;7.39,-.46,;5.85,-.46,)|	InChI=1S/C25H23ClF2N2O4/c1-32-9-10-33-18-8-7-15(24(30)31)21(23(18)28)20-16-12-25(13-29,14-5-3-2-4-6-14)34-19(16)11-17(27)22(20)26/h2-8,11H,9-10,12-13,29H2,1H3,(H2,30,31)	SUKGHSQJCSBWCC-UHFFFAOYSA-N	695291	US12083101, Example 37	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695291	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695291&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444072	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:2.29,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-.55,;.51,-1.02,;.51,-2.56,;1.97,-3.04,;-.83,			695292	US12083101, Example 38	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695292	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695292&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444073	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1cc(SC(F)(F)CO)ccc1C(N)=O)c1ccccc1 |r,wU:2.30,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-.55,;.51,-1.02,;.51,-2.56,;1.97,-3.04,;-.83,-3.33,;-2.16,-2.56,;-3.49,-3.33,;-2.16,-1.02,;-3.49,-.25,;-.83,-.25,;-.83,1.29,;-2.16,2.06,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-4.83,2.06,;-6.16,2.83,;-6.16,4.37,;-7.5,3.6,;-.83,4.37,;.51,3.6,;.51,2.06,;1.84,1.29,;3.17,2.06,;2.61,-.05,;4.			695293	US12083101, Example 39	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 102							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695293	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695293&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444074	CS(=O)(=O)COc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.31,(-7.5,3.05,;-6.16,3.82,;-7.25,4.91,;-5.07,4.91,;-4.83,3.05,;-3.49,3.82,;-2.16,3.05,;-.83,3.82,;.51,3.05,;.51,1.51,;1.84,.74,;3.17,1.51,;2.61,-.59,;-.83,.74,;-2.16,1.51,;-3.49,.74,;-.83,-.8,;.51,-1.57,;1.97,-1.09,;2.88,-2.34,;3.96,-3.43,;3.57,-4.91,;1.97,-3.58,;.51,-3.11,;-.83,-3.88,;-2.16,-3.11,;-3.49,-3.88,;-2.16,-1.57,;-3.49,-.8,;4.42,-2.34,;5.19,-3.67,;6.73,-3.67,;7.5,-2.34,;6.73,-1,;5.19,-1,)|	InChI=1S/C24H21ClF2N2O5S/c1-35(31,32)12-33-17-8-7-14(23(29)30)20(22(17)27)19-15-10-24(11-28,13-5-3-2-4-6-13)34-18(15)9-16(26)21(19)25/h2-9H,10-12,28H2,1H3,(H2,29,30)	HBJFNDSIQWNGKR-UHFFFAOYSA-N	695294	US12083101, Example 40	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 42.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695294	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695294&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444075	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:2.31,(4.23,-4.37,;4.63,-2.88,;3.54,-1.79,;2.64,-.55,;1.17,-1.02,;1.17,-2.56,;2.64,-3.04,;-.16,-3.33,;-1.49,-2.56,;-2.83,-3.33,;-1.49,-1.02,;-2.83,-.25,;-.16,-.25,;-.16,1.29,;-1.49,2.06,;-2.83,1.29,;-1.49,3.6,;-2.83,4.37,;-4.16,3.6,;-5.5,4.37,;-6.83,3.6,;-8.16,4.37,;-6.83,2.06,;-.16,4.37,;1.17,3.6,;1.17,2.06,;2.51,1.29,;3.84,2.06,;3.28,-.05,;5.08,-1.79,;5.85,-3.13,;7.39,-3.13,;8.16,-1.79,;7.39,-.46,;5.85,-.46,)|	InChI=1S/C25H21ClF4N2O3/c26-22-16(27)10-18-15(11-25(12-31,35-18)13-4-2-1-3-5-13)20(22)21-14(24(32)33)6-7-17(23(21)30)34-9-8-19(28)29/h1-7,10,19H,8-9,11-12,31H2,(H2,32,33)	ATJKUJONIASZCA-UHFFFAOYSA-N	695295	US12083101, Example 41	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 89.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695295	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695295&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444076	COc1ncc(C(N)=O)c(c1F)-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:15.27,(-6.16,3.6,;-4.83,4.37,;-3.49,3.6,;-2.16,4.37,;-.83,3.6,;-.83,2.06,;.51,1.29,;1.84,2.06,;1.28,-.05,;-2.16,1.29,;-3.49,2.06,;-4.83,1.29,;-2.16,-.25,;-.83,-1.02,;.64,-.55,;1.54,-1.79,;2.63,-2.88,;2.23,-4.37,;.64,-3.04,;-.83,-2.56,;-2.16,-3.33,;-3.49,-2			695296	US12083101, Example 42	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695296	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695296&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444077	NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ncc1C(N)=O)c1ccccc1 |r,wU:2.29,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-.55,;.51,-1.02,;.51,-2.56,;1.97,-3.04,;-.83,-3.33,;-2.16,-2.56,;-3.49,-3.33,;-2.16,-1.02,;-3.49,-.25,;-.83,-.25,;-.83,1.29,;-2.16,2.06,;-3.49,1.29,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-6.16,4.37,;-7.5,3.6,;-.83,4.37,;.51,3.6,;.51,2.06,;1.84,1.29,;3.17,2.06,;2.61,-.05,;4.42,-1.79,;5.19,-.46,;6.73,-.46,;7.5,-1.79,;6.73,-3.13,;5.19,-3.13,)|	InChI=1S/C23H20ClF2N3O4/c24-19-15(25)8-16-13(9-23(11-27,33-16)12-4-2-1-3-5-12)17(19)18-14(21(28)31)10-29-22(20(18)26)32-7-6-30/h1-5,8,10,30H,6-7,9,11,27H2,(H2,28,31)	OPYSPCRHDPCYQE-UHFFFAOYSA-N	695297	US12083101, Example 43	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695297	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695297&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444078	CNC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.30,(4.51,1.29,;3.17,2.06,;1.84,1.29,;2.61,-.05,;.51,2.06,;.51,3.6,;-.83,4.37,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-6.16,4.37,;-7.5,3.6,;-2.16,2.06,;-3.49,1.29,;-.83,1.29,;-.83,-.25,;.51,-1.02,;1.97,-.55,;2.88,-1.79,;3.96,-2.88,;3.57,-4.37,;1.97,-3.04,;.51,-2.56,;-.83,-3.33,;-2.16,-2.56,;-3.49,-3.33,;-2.16,-1.02,;-3.49,-.25,;4.42,-1.79,;5.19,-.46,;6.73,-.46,;7.5,-1.79,;6.73,-3.13,;5.19,-3.13,)|	InChI=1S/C25H23ClF2N2O4/c1-30-24(32)15-7-8-18(33-10-9-31)23(28)21(15)20-16-12-25(13-29,14-5-3-2-4-6-14)34-19(16)11-17(27)22(20)26/h2-8,11,31H,9-10,12-13,29H2,1H3,(H,30,32)	JGYGCHRLTWHDCM-UHFFFAOYSA-N	695298	US12083101, Example 44	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695298	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695298&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444079	CNC(=O)c1cnc(OCCO)c(F)c1-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.30,(4.51,1.29,;3.17,2.06,;1.84,1.29,;2.61,-.05,;.51,2.06,;.51,3.6,;-.83,4.37,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-6.16,4.37,;-7.5,3.6,;-2.16,2.06,;-3.49,1.29,;-.83,1.29,;-.83,-.25,;.51,-1.02,;1.97,-.55,;2.88,-1.79,;3.96,-2.88,;3.57,-4.37,;1.97,-3.04,;.51,-2.56,;-.83,-3.33,;-2.16,-2.56,;-3.49,-3.33,;-2.16,-1.02,;-3.49,-.25,;4.42,-1.79,;5.19,-.46,;6.73,-.46,;7.5,-1.79,;6.73,-3.13,;5.19,-3.13,)|	InChI=1S/C24H22ClF2N3O4/c1-29-22(32)15-11-30-23(33-8-7-31)21(27)19(15)18-14-10-24(12-28,13-5-3-2-4-6-13)34-17(14)9-16(26)20(18)25/h2-6,9,11,31H,7-8,10,12,28H2,1H3,(H,29,32)	VPDPGXSBFICCEH-UHFFFAOYSA-N	695299	US12083101, Example 45	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695299	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695299&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444080	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC)ccc1C(N)=O)c1ccccc1 |r,wU:3.28,(3.57,-4.75,;2.23,-3.98,;2.63,-2.5,;1.54,-1.41,;.64,-.16,;-.83,-.64,;-.83,-2.18,;.64,-2.65,;-2.16,-2.95,;-3.49,-2.18,;-4.83,-2.95,;-3.49,-.64,;-4.83,.13,;-2.16,.13,;-2.16,1.67,;-3.49,2.44,;-4.83,1.67,;-3.49,3.98,;-4.83,4.75,;-6.16,3.98,;-2.16,4.75,;-.83,3.98,;-.83,2.44,;.51,1.67,;1.84,2.44,;1.28,.34,;3.08,-1.41,;3.85,-.07,;5.39,-.07,;6.16,-1.41,;5.39,-2.74,;3.85,-2.74,)|	InChI=1S/C24H21ClF2N2O3/c1-29-12-24(13-6-4-3-5-7-13)11-15-18(32-24)10-16(26)21(25)19(15)20-14(23(28)30)8-9-17(31-2)22(20)27/h3-10,29H,11-12H2,1-2H3,(H2,28,30)	VVXZZNZJHJXQRA-UHFFFAOYSA-N	695300	US12083101, Example 46	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695300	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695300&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444081	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCOC)ncc1C(N)=O)c1ccccc1 |r,wU:3.31,(5.57,-4.75,;4.23,-3.98,;4.63,-2.5,;3.54,-1.41,;2.64,-.16,;1.17,-.64,;1.17,-2.18,;2.64,-2.65,;-.16,-2.95,;-1.49,-2.18,;-2.83,-2.95,;-1.49,-.64,;-2.83,.13,;-.16,.13,;-.16,1.67,;-1.49,2.44,;-2.83,1.67,;-1.49,3.98,;-2.83,4.75,;-4.16,3.98,;-5.5,4.75,;-6.83,3.98,;-8.16,4.75,;-.16,4.75,;1.17,3.98,;1.17,2.44,;2.51,1.67,;3.84,2.44,;3.28,.34,;5.08,-1.41,;5.85,-.07,;7.39,-.07,;8.16,-1.41,;7.39,-2.74,;5.85,-2.74,)|	InChI=1S/C25H24ClF2N3O4/c1-30-13-25(14-6-4-3-5-7-14)11-15-18(35-25)10-17(27)21(26)19(15)20-16(23(29)32)12-31-24(22(20)28)34-9-8-33-2/h3-7,10,12,30H,8-9,11,13H2,1-2H3,(H2,29,32)	MTNQICVZMYOCPL-UHFFFAOYSA-N	695301	US12083101, Example 47	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695301	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695301&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444082	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:3.30,(4.9,-4.75,;3.57,-3.98,;3.96,-2.5,;2.88,-1.41,;1.97,-.16,;.51,-.64,;.51,-2.18,;1.97,-2.65,;-.83,-2.95,;-2.16,-2.18,;-3.49,-2.95,;-2.16,-.64,;-3.49,.13,;-.83,.13,;-.83,1.67,;-2.16,2.44,;-3.49,1.67,;-2.16,3.98,;-3.49,4.75,;-4.83,3.98,;-6.16,4.75,;-7.5,3.98,;-.83,4.75,;.51,3.98,;.51,2.44,;1.84,1.67,;3.17,2.44,;2.61,.34,;4.42,-1.41,;5.19,-.07,;6.73,-.07,;7.5,-1.41,;6.73,-2.74,;5.19,-2.74,)|	InChI=1S/C25H23ClF2N2O4/c1-30-13-25(14-5-3-2-4-6-14)12-16-19(34-25)11-17(27)22(26)20(16)21-15(24(29)32)7-8-18(23(21)28)33-10-9-31/h2-8,11,30-31H,9-10,12-13H2,1H3,(H2,29,32)	CRRZMCWTGVHUCS-UHFFFAOYSA-N	695302	US12083101, Example 48	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695302	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695302&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444083	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ncc1C(N)=O)c1ccccc1 |r,wU:3.30,(4.9,-4.75,;3.57,-3.98,;3.96,-2.5,;2.88,-1.41,;1.97,-.16,;.51,-.64,;.51,-2.18,;1.97,-2.65,;-.83,-2.95,;-2.16,-2.18,;-3.49,-2.95,;-2.16,-.64,;-3.49,.13,;-.83,.13,;-.83			695303	US12083101, Example 49	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695303	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695303&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444084	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNCC3CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.34,(2.51,3.88,;1.17,3.11,;1.94,1.78,;-.16,3.88,;-.16,5.42,;-1.49,6.19,;-2.83,5.42,;-4.16,6.19,;-5.5,5.42,;-6.83,6.19,;-5.5,3.88,;-2.83,3.88,;-4.16,3.11,;-1.49,3.11,;-1.49,1.57,;-.16,.8,;1.3,1.28,;2.21,.03,;3.3,-1.06,;2.9,-2.55,;4.23,-3.32,;4.2			695304	US12083101, Example 50	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 30.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695304	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695304&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444085	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(=O)NC)c1ccccc1 |r,wU:3.31,(3.19			695305	US12083101, Example 51	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695305	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695305&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444086	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC[C@H](C)O)ccc1C(=O)NC)c1ccccc1 |r,wU:3.32,wD:20.23,(4.66,-5.68,;3.57,-4.59,;3.96,-3.11,;2.88,-2.02,;1.97,-.77,;.51,-1.25,;.51,-2.79,;1.97,-3.26,;-.83,-3.56,;-2.16,-2.79,;-3.49,-3.56,;-2.16,-1.25,;-3.49,-.48,;-.83,-.48,;-.83,1.06,;-2.16,1.83,;-3.49,1.06,;-2.16,3.37,;-3.49,4.14,;-4.83,3.37,;-6.16,4.14,;-7.5,3.37,;-6.16,5.68,;-.83,4.14,;.51,3.37,;.51,1.83,;1.84,1.06,;2.61,-.27,;3.17,1.83,;4.51,1.06,;4.42,-2.02,;5.19,-3.35,;6.73,-3.35,;7.5,-2.02,;6.73,-.68,;5.19,-.68,)|	InChI=1S/C27H27ClF2N2O4/c1-15(33)13-35-20-10-9-17(26(34)32-3)23(25(20)30)22-18-12-27(14-31-2,16-7-5-4-6-8-16)36-21(18)11-19(29)24(22)28/h4-11,15,31,33H,12-14H2,1-3H3,(H,32,34)	CFWWNUONNHZZBL-UHFFFAOYSA-N	695306	US12083101, Example 52	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695306	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695306&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444087	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ncc1C(=O)NC)c1ccccc1 |r,wU:3.31,(4.66,-4.91,;3.57,-3.82,;3.96,-2.34,;2.88,-1.25,;1.97,-0,;.51,-.48,;.51,-2.02,;1.97,-2.49,;-.83,-2.79,;-2.16,-2.02,;-3.49,-2.79,;-2.16,-.48,;-3.49,.29,;-.83,.29,;-.83,1.83,;-2.16,2.6,;-3.49,1.83,;-2.16,4.14,;-3.49,4.91,;-4.83,4.14,;-6.16,4.91,;-7.5,4.14,;-.83,4.91,;.51,4.14,;.51,2.6,;1.84,1.83,;2.61,.5,;3.17,2.6,;4.51,1.83,;4.42,-1.25,;5.19,-2.58,;6.73,-2.58,;7.5,-1.25,;6.73,.09,;5.19,.09,)|	InChI=1S/C25H24ClF2N3O4/c1-29-13-25(14-6-4-3-5-7-14)11-15-18(35-25)10-17(27)21(26)19(15)20-16(23(33)30-2)12-31-24(22(20)28)34-9-8-32/h3-7,10,12,29,32H,8-9,11,13H2,1-2H3,(H,30,33)	MBRKEYWFYWPQTA-UHFFFAOYSA-N	695307	US12083101, Example 53	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695307	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695307&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444088	CS(=O)(=O)[C@@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:12.40,7.10,4.3,(6.3,3.07,;6.3,4.61,;7.79,4.21,;7.07,5.94,;5.21,5.69,;5.61,7.18,;4.52,8.27,;3.03,7.87,;2.63,6.39,;3.72,5.3,;1.94,8.96,;2.34,10.45,;1.25,11.54,;.35,12.78,;-1.12,12.31,;-1.12,10.77,;.35,10.29,;-2.45,10,;-3.78,10.77,;-5.12,10,;-3.78,12.31,;-5.12,13.08,;-2.45,13.08,;-2.45,14.62,;-3.78,15.39,;-5.12,14.62,;-3.78,16.93,;-5.12,17.7,;-6.45,16.93,;-7.79,17.7,;-6.45,15.39,;-2.45,17.7,;-1.12,16.93,;-1.12,15.39,;.22,14.62,;1.55,15.39,;.99,13.28,;2.79,11.			695308	US12083101, Example 54a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 75.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695308	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695308&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444089	CS(=O)(=O)[C@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:12.40,7.10,wD:4.3,(6.3,3.07,;6.3,4.61,;7.79,4.21,;7.07,5.94,;5.21,5.69,;5.61,7.18,;4.52,8.27,;3.03,7.87,;2.63,6.39,;3.72,5.3,;1.94,8.96,;2.34,10.45,;1.25,11.54,;.35,12.78,;-1.12,12.31,;-1.12,10.77,;.35,10.29,;-2.45,10,;-3.78,10.77,;-5.12,10,;-3.78,12.31,;-5.12,13.08,;-2.45,13.08,;-2.45,14.62,;-3.78,15.39,;-5.12,14.62,;-3.78,16.93,;-5.12,17.7,;-6.45,16.93,;-7.79,17.7,;-6.45,15.39,;-2.45,17.7,;-1.12,16.93,;-1.12,15.39,;.22,14.62,;1.55,15.39,;.99,13.28,;2.79,11.54,;3.56,10.2,;5.1,10.2,;5.87,11.54,;5.1,12.87,;3.56,12.87,)|	InChI=1S/C30H29ClF4N2O5S/c1-43(39,40)18-9-7-17(8-10-18)37-15-30(16-5-3-2-4-6-16)14-20-23(42-30)13-21(32)26(31)24(20)25-19(28(36)38)11-12-22(27(25)33)41-29(34)35/h2-6,11-13,17-18,29,37H,7-10,14-15H2,1H3,(H2,36,38)	FLNKRRLRIHUISZ-UHFFFAOYSA-N	695309	US12083101, Example 54b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 22.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695309	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695309&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444090	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNC3CCC(O)(CF)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.39,(1.97,4.82,;.64,4.05,;1.41,2.72,;-.7,4.82,;-.7,6.36,;-2.03,7.13,;-3.36,6.36,;-4.7,7.13,;-6.03,6.36,;-7.36,7.13,;-6.03,4.82,;-3.36,4.82,;-4.7,4.05,;-2.03,4.05,;-2.03,2.51,;-.7,1.74,;.77,2.22,;1.67,.97,;2.76,-.12,;2.36,-1.61,;3.45,-2.7,;3.06,-4.18,;4.14,-5.27,;5.63,-4.87,;7.12,-4.47,;6.03,-6.36,;7.36,-7.13,;6.03,-3.39,;4.94,-2.3,;.77,-.28,;-.7,.2,;-2.03,-.57,;-3.36,.2,;-4.7,-.57,;-3.36,1.74			695310	US12083101, Example 55b::US12083101, Example 55a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		<1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695310	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695310&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444091	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNC3CCC(O)(CF)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.39,(1.97,4.82,;.64,4.05,;1.41,2.72,;-.7,4.82,;-.7,6.36,;-2.03,7.13,;-3.36,6.36,;-4.7,7.13,;-6.03,6.36,;-7.36,7.13,;-6.03,4.82,;-3.36,4.82,;-4.7,4.05,;-2.03,4.05,;-2.03,2.51,;-.7,1.74,;.77,2.22,;1.67,.97,;2.76,-.12,;2.36,-1.61,;3.45,-2.7,;3.06,-4.18,;4.14,-5.27,;5.63,-4.87,;7.12,-4.47,;6.03,-6.36,;7.36,-7.13,;6.03,-3.39,;4.94,-2.3,;.77,-.28,;-.7,.2,;-2.03,-.57,;-3.36,.2,;-4.7,-.57,;-3.36,1.74			695310	US12083101, Example 55b::US12083101, Example 55a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695310	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695310&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444092	CC(=O)NC1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:12.40,(8.33,-6.89,;7.24,-5.8,;7.64,-4.31,;5.75,-6.2,;4.66,-5.11,;3.18,-5.51,;2.09,-4.42,;2.49,-2.93,;3.97,-2.54,;5.06,-3.62,;1.4,-1.85,;1.8,-.36,;.71,.73,;-.2,1.98,;-1.66,1.5,;-1.66,-.04,;-.2,-.51,;-3,-.81,;-4.33,-.04,;-5.66,-.81,;-4.33,1.5,;-5.66,2.27,;-3,2.27,;-3,3.81,;-4.33,4.58,;-5.66,3.81,;-4.33,6.12,;-5.66			695312	US12083101, Example 56b::US12083101, Example 56a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695312	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695312&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444093	CC(=O)NC1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:12.40,(8.33,-6.89,;7.24,-5.8,;7.64,-4.31,;5.75,-6.2,;4.66,-5.11,;3.18,-5.51,;2.09,-4.42,;2.49,-2.93,;3.97,-2.54,;5.06,-3.62,;1.4,-1.85,;1.8,-.36,;.71,.73,;-.2,1.98,;-1.66,1.5,;-1.66,-.04,;-.2,-.51,;-3,-.81,;-4.33,-.04,;-5.66,-.81,;-4.33,1.5,;-5.66,2.27,;-3,2.27,;-3,3.81,;-4.33,4.58,;-5.66,3.81,;-4.33,6.12,;-5.66			695312	US12083101, Example 56b::US12083101, Example 56a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695312	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695312&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444094	CS(=O)(=O)NC1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:13.41,(8.58,-5.78,;7.04,-5.78,;7.04,-4.24,;7.04,-7.32,;5.5,-5.78,;4.41,-4.69,;2.93,-5.09,;1.84,-4,;2.24,-2.51,;3.72,-2.11,;4.81,-3.2,;1.15,-1.42,;1.55,.07,;.46,1.16,;-.45,2.4,;-1.91,1.93,;-1.91,.39,;-.45,-.09,;-3.25,-.38,;-4.58,.			695314	US12083101, Example 57b::US12083101, Example 57a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695314	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695314&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444095	CS(=O)(=O)NC1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:13.41,(8.58,-5.78,;7.04,-5.78,;7.04,-4.24,;7.04,-7.32,;5.5,-5.78,;4.41,-4.69,;2.93,-5.09,;1.84,-4,;2.24,-2.51,;3.72,-2.11,;4.81,-3.2,;1.15,-1.42,;1.55,.07,;.46,1.16,;-.45,2.4,;-1.91,1.93,;-1.91,.39,;-.45,-.09,;-3.25,-.38,;-4.58,.			695314	US12083101, Example 57b::US12083101, Example 57a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695314	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695314&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444096	CN(C)C(=O)C1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:13.41,(8.33,-6.49,;7.24,-5.4,;7.64,-3.92,;5.75,-5.8,;5.36,-7.29,;4.66,-4.71,;3.18,-5.11,;2.09,-4.02,;2.49,-2.54,;3.97,-2.14,;5.06,-3.23,;1.4,-1.45,;1.			695316	US12083101, Example 58b::US12083101, Example 58a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695316	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695316&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444097	CN(C)C(=O)C1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:13.41,(8.33,-6.49,;7.24,-5.4,;7.64,-3.92,;5.75,-5.8,;5.36,-7.29,;4.66,-4.71,;3.18,-5.11,;2.09,-4.02,;2.49,-2.54,;3.97,-2.14,;5.06,-3.23,;1.4,-1.45,;1.			695316	US12083101, Example 58b::US12083101, Example 58a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695316	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695316&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444098	NC(=O)c1ccc(OC(F)F)c(F)c1c6c(Cl)c(F)cc5O[C@](CNC3CCC2(CCC(=O)N2)CC3)(c4ccccc4)Cc56	InChI=1S/C32H30ClF4N3O4/c33-27-21(34)14-23-20(25(27)26-19(29(38)42)6-7-22(28(26)35)43-30(36)37)15-32(44-23,17-4-2-1-3-5-17)16-39-18-8-11-31(12-9-18)13-10-24(41)40-31/h1-7,14,18,30,39H,8-13,15-16H2,(H2,38,42)(H,40,41)	LKGPXXCSTHHGHO-UHFFFAOYSA-N	695318	US12083101, Example 59a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695318	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695318&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search			166749136	505364471							3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444099	NC(=O)c1ccc(OC(F)F)c(F)c1c6c(Cl)c(F)cc5O[C@](CNC3CCC2(CCC(=O)N2)CC3)(c4ccccc4)Cc56	InChI=1S/C32H30ClF4N3O4/c33-27-21(34)14-23-20(25(27)26-19(29(38)42)6-7-22(28(26)35)43-30(36)37)15-32(44-23,17-4-2-1-3-5-17)16-39-18-8-11-31(12-9-18)13-10-24(41)40-31/h1-7,14,18,30,39H,8-13,15-16H2,(H2,38,42)(H,40,41)	LKGPXXCSTHHGHO-UHFFFAOYSA-N	695319	US12083101, Example 59b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695319	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695319&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search			166749136	505364472							3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444100	CN(C)C(=O)CN1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:14.42,(7.19,-7.64,;7.59,-6.15,;9.07,-5.75,;6.5,-5.06,;6.9,-3.57,;5.01,-5.46,;3.92,-4.37,;2.43,-4.77,;1.34,-3.68,;1.74,-2.19,;3.23,-1.79,;4.32,-2.88,;			695320	US12083101, Example 60	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 20.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695320	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695320&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444101	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNC3CCC(CO)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.38,(2.29,4.98,;.96,4.21,;1.73,2.88,;-.37,4.98,;-.37,6.52,;-1.71,7.29,;-3.04,6			695321	US12083101, Example 61b::US12083101, Example 61a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 8.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695321	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695321&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444102	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNC3CCC(CO)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.38,(2.29,4.98,;.96,4.21,;1.73,2.88,;-.37,4.98,;-.37,6.52,;-1.71,7.29,;-3.04,6			695321	US12083101, Example 61b::US12083101, Example 61a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695321	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695321&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444103	CC(C)(O)C1CC(C1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:10.38,(7.47,-5.08,;5.98,-5.48,;6.38,-4,;5.58,-6.97,;4.89,-4.39,;3.35,-4.39			695323	US12083101, Example 62b::US12083101, Example 62a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 16.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695323	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695323&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444104	CC(C)(O)C1CC(C1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:10.38,(7.47,-5.08,;5.98,-5.48,;6.38,-4,;5.58,-6.97,;4.89,-4.39,;3.35,-4.39			695323	US12083101, Example 62b::US12083101, Example 62a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695323	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695323&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444105	CS(=O)(=O)N1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:12.40,(7.59,-7.09,;6.5,-6,;7.59,-4.91,;5.41,-7.09,;5.41,-4.91,;3.92,-5.31,;2.83,-4.22,;3.23,-2.73,;4.72,-2.34,;5.81,-3.43,;2.14,-1.65,;2.54,-.16,;1.45,.93,;.55,2.18,;-.92,1.7,;-.92,.16,;.55,-.32,;-2.25,-.61,;-3.59,.16,;-4.92,-.61,;-3.59,1.7,;-4.92,2.47,;-2.25,2.47,;-2.25,4.01,;-3.59,4.78,;-4.92,4.01,;-3.59,6.32,;-4.92,7.09,;-6.25,6.32,;-7.59,7.09,;-6.25,4.78,;-2.25,7.09,;-.92,6.32,;-.92,4.78,;.42,4.01,;1.75,4.78,;1.19,2.68,;2.99,.93,;3.76,-.4,;5.3,-.4,;6.07,.93,;5.3,2.26,;3.76,2.26,)|	InChI=1S/C29H28ClF4N3O5S/c1-43(39,40)37-11-9-17(10-12-37)36-15-29(16-5-3-2-4-6-16)14-19-22(42-29)13-20(31)25(30)23(19)24-18(27(35)38)7-8-21(26(24)32)41-28(33)34/h2-8,13,17,28,36H,9-12,14-15H2,1H3,(H2,35,38)	NXKHFEFDBVDWRX-UHFFFAOYSA-N	695325	US12083101, Example 63	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 69.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695325	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695325&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444106	NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](CN[C@H]3C[C@H](CO)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.36,20.20,wD:22.23,(2.54,3.92,;1.2,3.15,;1.97,1.81,;-.13,3.92,;-.13,5.46,;-1.47,6.23,;-2.8,5.46,;-4.13,6.23,;-5.47,5.46,;-6.8,6.23,;-8.13,5.46,;-2.8,3.92,;-4.13,3.15,;-1.47,3.15,;-1.47,1.61,;-.13,.84,;1.33,1.31,;2.24,.07,;3.33,-1.02,;2.93,-2.51,;4.02,-3.6,;5.56,-3.6,;5.56,-5.14,;6.65,-6.23,;8.13,-5.83,;4.02,-5.14,;1.33,-1.18,;-.13,-.7,;-1.47,-1.47,;-2.8,-.7,;-4.13,-1.47,;-2.8,.84,;-4.13,1.61,;3.78,.07,;4.55,-1.27,;6.09,-1.27,;6.86,.07,;6.09,1.4,;4.55,1.4,)|	InChI=1S/C29H29ClF2N2O5/c30-26-21(31)12-23-20(24(26)25-19(28(33)37)6-7-22(27(25)32)38-9-8-35)13-29(39-23,17-4-2-1-3-5-17)15-34-18-10-16(11-18)14-36/h1-7,12,16,18,34-36H,8-11,13-15H2,(H2,33,37)	FXCGDFCUFXEYPN-UHFFFAOYSA-N	695326	US12083101, Example 64a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695326	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695326&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444107	NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](CN[C@@H]3C[C@H](CO)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.36,20.20,22.23,(2.54,3.92,;1.2,3.15,;1.97,1.81,;-.13,3.92,;-.13,5.46,;-1.47,6.23,;-2.8,5.46,;-4.13,6.23,;-5.47,5.46,;-6.8,6.23,;-8.13,5.46,;-2.8,3.92,;-4.13,3.15,;-1.47,3.15,;-1.47,1.61,;-.13,.84,;1.33,1.31,;2.24,.07,;3.33,-1.02,;2.93,-2.51,;4.02,-3.6,;4.02,-5.14,;5.56,-5.14,;6.65,-6.23,;8.13,-5.83,;5.56,-3.6,;1.33,-1.18,;-.13,-.7,;-1.47,-1.47,;-2.8,-.7,;-4.13,-1.47,;-2.8,.84,;-4.13,1.61,;3.78,.07,;4.55,-1.27,;6.09,-1.27,;6.86,.07,;6.09,1.4,;4.55,1.4,)|	InChI=1S/C29H29ClF2N2O5/c30-26-21(31)12-23-20(24(26)25-19(28(33)37)6-7-22(27(25)32)38-9-8-35)13-29(39-23,17-4-2-1-3-5-17)15-34-18-10-16(11-18)14-36/h1-7,12,16,18,34-36H,8-11,13-15H2,(H2,33,37)	FXCGDFCUFXEYPN-UHFFFAOYSA-N	695327	US12083101, Example 64b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695327	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695327&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444108	C[C@H]1C[C@H](C[C@@H](C)O1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:10.38,3.8,1.0,5.5,(4.34,-6.94,;4.73,-5.46,;3.65,-4.37,;4.04,-2.88,;5.53,-2.48,;6.62,-3.57,;8.11,-3.17,;6.22,-5.06,;2.95,-1.79,;3.35,-.3,;2.26,.78,;1.36,2.03,;-.11,1.55,;-.11,.01,;1.36,-.46,;-1.44,-.76,;-2.77,.01,;-4.11,-.76,;-2.77,1.55,;-4.11,2.32,;-1.44,2.32,;-1.44,3.86,;-2.77,4.63,;-4.11,3.86,;-2.77,6.17,;-4.11,6.94,;-5.44,6.17,;-6.77,6.94,;-8.11,6.17,;-1.44,6.94,;-.11,6.17,;-.11,4.63,;1.23,3.86,;2.56,4.63,;2,2.53,;3.8,.78,;4.57,-.55,;6.11,-.55,;6.88,.78,;6.11,2.12,;4.57,2.12,)|	InChI=1S/C31H33ClF2N2O5/c1-17-12-20(13-18(2)40-17)36-16-31(19-6-4-3-5-7-19)15-22-25(41-31)14-23(33)28(32)26(22)27-21(30(35)38)8-9-24(29(27)34)39-11-10-37/h3-9,14,17-18,20,36-37H,10-13,15-16H2,1-2H3,(H2,35,38)	GNQVIHDNAPTYDM-UHFFFAOYSA-N	695328	US12083101, Example 65a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695328	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695328&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444109	C[C@H]1C[C@@H](C[C@@H](C)O1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:10.38,1.0,5.5,wD:3.8,(4.34,-6.94,;4.73,-5.46,;3.65,-4.37,;4.04,-2.88,;5.53,-2.48,;6.62,-3.57,;8.11,-3.17,;6.22,-5.06,;2.95,-1.79,;3.35,-.3,;2.26,.78,;1.36,2.03,;-.11,1.55,;-.11,.01,;1.36,-.46,;-1.44,-.76,;-2.77,.01,;-4.11,-.76,;-2.77,1.55,;-4.11,2.32,;-1.44,2.32,;-1.44,3.86,;-2.77,4.63,;-4.11,3.86,;-2.77,6.17,;-4.11,6.94,;-5.44,6.17,;-6.77,6.94,;-8.11,6.17,;-1.44,6.94,;-.11,6.17,;-.11,4.63,;1.23,3.86,;2.56,4.63,;2,2.53,;3.8,.78,;4.57,-.55,;6.11,-.55,;6.88,.78,			695329	US12083101, Example 65b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 455							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695329	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695329&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444110	COc1ncc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:15.36,18.18,21.22,wD:21.23,(-6.6,5.98,;-5.27,6.75,;-3.93,5.98,;-2.6,6.75,;-			695330	US12083101, Example 66a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695330	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695330&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444111	COc1ncc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:15.36,18.18,21.23,wD:21.22,(-6.6,5.98,;-5.27,6.75,;-3.93,5.98,;-2.6,6.75,;			695331	US12083101, Example 66b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695331	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695331&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444112	C[C@@]1(O)CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC[C@H]2CCCO2)ccc1C(N)=O)c1ccccc1 |r,wU:10.42,5.8,1.1,27.29,wD:1.0,(8.49,-6.18,;6.95,-6.18,;7.34,-7.			695332	US12083101, Example 67a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695332	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695332&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444113	C[C@]1(O)CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC[C@H]2CCCO2)ccc1C(N)=O)c1ccccc1	InChI=1S/C34H37ClF2N2O5/c1-33(41)13-11-21(12-14-33)39-19-34(20-6-3-2-4-7-20)17-24-27(44-34)16-25(36)30(35)28(24)29-23(32(38)40)9-10-26(31(29)37)43-18-22-8-5-15-42-22/h2-4,6-7,9-10,16,21-22,39,41H,5,8,11-15,17-19H2,1H3,(H2,38,40)	APGVWRIETDWOKI-UHFFFAOYSA-N	695333	US12083101, Example 67b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695333	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695333&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444114	CCc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:15.36,18.18,21.22,wD:21.23,(-6.6,5.98,;-5.27,6.75,;-3.93,5.98,;-2.6,6.75,;-1.27,5.98,;-1.27,4.44,;.07,3.67,;1.4,4.44,;.84,2.33,;-2.6,3.67,;-3.93,4.44,;-5.27,3.67,;-2.6,2.13,;-1.27,1.36,;.2,1.83,;1.1,.59,;2.19,-.5,;1.79,-1.99,;2.88,-3.08,;4.37,-2.68,;5.46,-3.77,;5.06,-5.26,;6.6,-5.26,;5.46,-6.75,;3.57,-5.66,;2.48,-4.57,;.2,-.66,;-1.27,-.18,;-2.6,-.95,;-3.93,-.18,;-5.27,-.95,;-3.93,1.36,;-5.27,			695334	US12083101, Example 68a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695334	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695334&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444115	CCc1ccc(C(N)=O)c(c1F)-c1c2C[C@](CN[C@H]3CC[C@@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:15.36,18.18,21.23,wD:21.22,(-6.6,5.9,;-5.27,6.67,;-3.93,5.9,;-2.6,6.67,;-1.27,5.9,;-1.27,4.36,;.07,3.59,;1.4,4.36,;.84,2.25,;-2.6,3.59,;-3.93,4.36,;-5.27,3.59,;-2.6,2.05,;-1.27,1.28,;.2,1.75,;1.1,.51,;2.19,-.58,;1.79,-2.07,;2.88,-3.16,;4.37,-2.76,;5.46,-3.85,;5.06,-5.33,;6.6,-5.33,;5.83,-6.67,;3.57,-5.73,;2.48,-4.64,;.2,-.74,;-1.27,-.26,;-2.6,-1.03,;-3.93,-.26,;-5.27,-1.03,;-3.93,1.28,;-5.27			695335	US12083101, Example 68b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 12.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695335	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695335&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444116	C[C@]1(O)CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(ccc1C(N)=O)-n1ccnc1)c1ccccc1 |r,wU:10.40,5.8,1.0,wD:1.1,(7.15,-6.18,;5.61,-6.18,;6.01,-7.67,;6.01,-4.7,;4.92,-3.61,;3.43,-4.01,;3.04,-5.49,;4.13,-6.58,;2.35,-2.92,;2.74,-1.43,;1.66,-.34,;.75,.91,;-.71,.43,;-.71,-1.11,;.75,-1.59,;-2.05,-1.88,;-3.38,-1.11,;-4.72,-1.88,;-3.38,.43,;-4.72,1.2,;-2.05,1.2,;-2.05,2.74,;-3.38,3.51,;-4.72,2.74,;-3.38,5.05,;-2.05,5.82,;-.71,5.05,;-.71,3.51,;.62,2.74,;1.95,3.51,;1.39,1.41,;-4.72,			695336	US12083101, Example 69a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695336	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695336&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444117	C[C@@]1(O)CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(ccc1C(N)=O)-n1ccnc1)c1ccccc1 |r,wU:10.40,5.8,1.1,wD:1.0,(7.15,-6.26,;5.61,-6.26,;6.38,-7.59,;6.01,-4.77,;4.92,-3.68,;3.43,-4.08,;3.04,-5.57,;4.13,-6.66,;2.35,-2.99,;2.74,-1.51,;1.66,-.42,;.75,.83,;-.71,.35,;-.71,-1.19,;.75,-1.66,;-2.05,-1.96,;-3.38,-1.19,;-4.72,-1.96,;-3.38,.35,;-4.72,1.12,;-2.05,1.12,;-2.05,2.66,;-3.38,3.43,;-4.72,2.66,;			695337	US12083101, Example 69b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695337	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695337&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444118	CC(=O)N1CCC(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:11.39,(5.9,-7.29,;6.3,-5.8,;7.79,-5.4,;5.21,-4.71,;3.72,-5.11,;2.63,-4.02,;3.03,-2.54,;4.52,-2.14,;5.61,-3.23,;1.94,-1.45,;2.34,.04,;1.25,1.13,;.35,2.38,;			695338	US12083101, Example 70	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 20.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695338	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695338&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444119	C[C@]1(O)CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCc2ncccn2)ccc1C(N)=O)c1ccccc1 |r,wU:10.43,5.8,1.0,wD:1.1,(7.83,-7.82,;7.06,-6.49,;8.6,-6.49,;7.46,-5,;6.37,-3.91,;4.88,-4.31,;4.48,-5.8,;5.57,-6.89,;3.79,-3.22,;4.19,-1.74,;3.1,-.65,;2.2,.6,;.73,.12,;.73,-1.42,;2.2,-1.89,;-.6,-2.19,;-1.93,-1.42,;-3.27,-2.19,;-			695339	US12083101, Example 71a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695339	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695339&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444120	C[C@@]1(O)CC[C@@H](CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCc2ncccn2)ccc1C(N)=O)c1ccccc1 |r,wU:10.43,5.8,1.1,wD:1.0,(7.83,-7.82,;7.06,-6.49,;8.6,-6.49,;7.46,-			695340	US12083101, Example 71b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695340	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695340&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444121	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@H]3CC[C@H](O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.37,20.20,wD:23.24,(2.29,4.24,;.96,3.47,;1.73,2.13,;-.37,4.24,;-.37,5.78,;-1.71,6.55,;-3.04,5.78,;-4.37,6.55,;-5.71,5.78,;-7.04,6.55,;-5.71,4.24,;-3.04,4.24,;-4.37,3.47,;-1.71,3.47,;-1.71,1.93,;-.37,1.16,;1.09,1.63,;2,.39,;3.09,-.7,;2.69,-2.19,;3.78,-3.28,;5.26,-2.88,;6.35,-3.97,;5.95,-5.46,;7.04,-6.55,;4.47,-5.86,;3.38,-4.77,;1.09,-.86,;-.37,-.38,;-1.71,-1.15,;-3.04,-.38,;-4.37,-1.15,;-3.04,1.16,;-4.37,1.93,;3.54,.39,;4.31,-.95,;5.85,-.95,;6.62,.39,;5.85,1.72,;4.31,1.72,)|	InChI=1S/C29H27ClF4N2O4/c30-25-20(31)12-22-19(23(25)24-18(27(35)38)10-11-21(26(24)32)39-28(33)34)13-29(40-22,15-4-2-1-3-5-15)14-36-16-6-8-17(37)9-7-16/h1-5,10-12,16-17,28,36-37H,6-9,13-14H2,(H2,35,38)	FXFZYILRQQAUGE-UHFFFAOYSA-N	695341	US12083101, Example 72	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695341	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695341&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444122	CC(C)(C)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:6.33,(6.12,-3.64,;4.63,-4.04,;4.23,-5.52,;5.03,-2.55,;3.54,-2.95,;3.54,-1.41,;2.21,-.64,;1.3,.61,;-.16,.13,;-.16,-1.41,;1.3,-1.88,;-1.49,-2.18,;-2.83,-1.41,;-4.16,-2.18,;-2.83,.13,;-4.16,.9,;-1.49,.9,;-1.49,2.44,;-2.83,3.21,;-4.16,2.44,;-2.83,4.75,;-4.16,5.52,;-5.5,4.75,;-6.83,5.52,;-5.5,3.21,;-1.49,5.52,;-.16,4.75,;-.16,3.21,;1.17,2.44,;2.51,3.21,;1.94,1.11,;3.75,-.64,;4.52,-1.97,;6.06,-1.97,;6.83,-.64,;6.06,.7,;4.52,.7,)|	InChI=1S/C27H25ClF4N2O3/c1-26(2,3)34-13-27(14-7-5-4-6-8-14)12-16-19(37-27)11-17(29)22(28)20(16)21-15(24(33)35)9-10-18(23(21)30)36-25(31)32/h4-11,25,34H,12-13H2,1-3H3,(H2,33,35)	YECRSUYUURBCCN-UHFFFAOYSA-N	695342	US12083101, Example 73	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 14.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695342	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695342&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444123	C[C@@H](O)CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:6.33,wD:1.1,(2.75,-5.38,;4.23,-4.98,;5.32,-6.07,;4.63,-3.49,;3.54,-2.4,;3.54,-.86,;2.21,-.09,;1.3,1.15,;-.16,.68,;-.16,-.86,;1.3,-1.34,;-1.49,-1.63,;-2.83,-.86,;-4.16,-1.63,;-2.83,.68,;-4.16,1.45,;-1.49,1.45,;-1.49,2.99,;-2.83,3.76,;-4.16,2.99,;-2.83,5.3,;-4.16,6.07,;-5.5,5.3,;-6.83,6.07,;-5.5,3.76,;-1.49,6.07,;-.16,5.3,;-.16,3.76,;1.17,2.99,;2.51,3.76,;1.94,1.65,;3.75,-.09,;4.52,-1.43,;6.06,-1.43,;6.83,-.09,;6.06,1.24,;4.52,1.24,)|	InChI=1S/C26H23ClF4N2O4/c1-13(34)11-33-12-26(14-5-3-2-4-6-14)10-16-19(37-26)9-17(28)22(27)20(16)21-15(24(32)35)7-8-18(23(21)29)36-25(30)31/h2-9,13,25,33-34H,10-12H2,1H3,(H2,32,35)	JZMGDJUEEZVWGM-UHFFFAOYSA-N	695343	US12083101, Example 74	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 33.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695343	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695343&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444124	C[C@@H](CO)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:6.33,1.0,(6.12,-3.09,;4.63,-3.49,;4.23,-4.98,;5.32,-6.07,;3.54,-2.4,;3.54,-.86,;2.21,-.09,;1.3,1.15,;-.16,.68,;-.16,-.86,;1.3,-1.34,;-1.49,-1.63,;-2.83,-.86,;-4.16,-1.63,;-2.83,.68,;-4.16,1.45,;-1.49,1.45,;-1.49,2.99,;-2.83,3.76,;-4.16,2.99,;-2.83,5.3,;-4.16,6.07,;-5.5,5.3,;-6.83,6.07,;-5.5,3.76,;-1.49,6.07,;-.16,5.3,;-.16,3.76,;1.17,2.99,;2.51,3.76,;1.94,1.65,;3.75,-.09,;4.52,-1.43,;6.06,-1.43,;6.83,-.09,;6.06,1.24,;4.52,1.24,)|	InChI=1S/C26H23ClF4N2O4/c1-13(11-34)33-12-26(14-5-3-2-4-6-14)10-16-19(37-26)9-17(28)22(27)20(16)21-15(24(32)35)7-8-18(23(21)29)36-25(30)31/h2-9,13,25,33-34H,10-12H2,1H3,(H2,32,35)	DWJJKVDYHWWMJZ-UHFFFAOYSA-N	695344	US12083101, Example 75	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 38.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695344	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695344&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444125	CC1(CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:6.34,(6.12,-3.64,;4.63,-4.04,;4.23,-5.52,;5.72,-5.12,;3.54,-2.95,;3.54,-1.41,;2.21,-.64,;1.3,.61,;-.16,.13,;-.16,-1.41,;1.3,-1.88,;-1.49,-2.18,;-2.83,-1.41,;-4.16,-2.18,;-2.83,.13,;-4.16,.9,;-1.49,.9,;-1.49,2.44,;-2.83,3.21,;-4.16,2.44,;-2.83,4.75,;-4.16,5.52,;-5.5,4.75,;-6.83,5.52,;-5.5,3.21,;-1.49,5.52,;-.16,4.75,;-.16,3.21,;1.17,2.44,;2.51,3.21,;1.94,1.11,;3.75,-.64,;4.52,-1.97,;6.06,-1.97,;6.83,-.64,;6.06,.7,;4.52,.7,)|	InChI=1S/C27H23ClF4N2O3/c1-26(9-10-26)34-13-27(14-5-3-2-4-6-14)12-16-19(37-27)11-17(29)22(28)20(16)21-15(24(33)35)7-8-18(23(21)30)36-25(31)32/h2-8,11,25,34H,9-10,12-13H2,1H3,(H2,33,35)	SKPYLKNEHDYAFB-UHFFFAOYSA-N	695345	US12083101, Example 76	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 50.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695345	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695345&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444126	COCCNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:6.33,(7.76,-4.73,;6.27,-5.12,;5.19,-4.04,;3.7,-4.43,;2.61,-3.35,;2.61,-1.81,;1.28,-1.04,;.37,.21,;-1.09,-.27,;-1.09,-1.81,;.37,-2.28,;-2.43,-2.58,;-3.76,-1.81,;-5.1,-2.58,;-3.76,-.27,;-5.1,.5,;-2.43,.5,;-2.43,2.04,;-3.76,2.81,;-5.1,2.04,;-3.76,4.35,;-5.1,5.12,;-6.43,4.35,;-7.76,5.12,;-6.43,2.81,;-2.43,5.12,;-1.09,4.35,;-1.09,2.81,;.24,2.04,;1.57,2.81,;1.01,.71,;2.82,-1.04,;3.59,-2.37,;5.13,-2.37,;5.9,-1.04,;5.13,.3,;3.59,.3,)|	InChI=1S/C26H23ClF4N2O4/c1-35-10-9-33-13-26(14-5-3-2-4-6-14)12-16-19(37-26)11-17(28)22(27)20(16)21-15(24(32)34)7-8-18(23(21)29)36-25(30)31/h2-8,11,25,33H,9-10,12-13H2,1H3,(H2,32,34)	VWICINQGWIXHTD-UHFFFAOYSA-N	695346	US12083101, Example 77	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 71.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695346	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695346&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444127	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNCCN3CCCC3=O)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.38,(1.13,3.82,;-.2,3.05,;.57,1.72,;-1.54,3.82,;-1.54,5.36,;-2.87,6.13,;-4.2,5.36,;-5.54,6.13,;-6.87,5.36,;-8.2,6.13,;-6.87,3.82,;-4.2,3.82,;-5.54,3.05,;-2.87,3.05,;-2.87,1.51,;-1.54,.74,;-.07,1.22,;.83,-.03,;2.17,-.8,;2.17,-2.34,;3.26,-3.43,;4.74,-3.03,;5.83,-4.12,;5.83,-5.66,;7.3,-6.13,;8.2,-4.89,;7.3,-3.64,;7.7,-2.15,;-.07,-1.27,;-1.54,-.8,;-2.87,-1.57,;-4.2,-.8,;-5.54,-1.57,;-4.2,.74,;-5.54,1.51,;2.37,-.03,;3.14,-1.36,;4.68,-1.36,;5.45,-.03,;4.68,1.31,;3.14,1.31,)|	InChI=1S/C29H26ClF4N3O4/c30-25-19(31)13-21-18(23(25)24-17(27(35)39)8-9-20(26(24)32)40-28(33)34)14-29(41-21,16-5-2-1-3-6-16)15-36-10-12-37-11-4-7-22(37)38/h1-3,5-6,8-9,13,28,36H,4,7,10-12,14-15H2,(H2,35,39)	QAIHVQVJHBAGBI-UHFFFAOYSA-N	695347	US12083101, Example 78	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 160							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695347	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695347&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444128	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@H]3CC[C@@H](CC3)n3cnnn3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.42,23.27,wD:20.20,(.79,5.11,;-.55,4.34,;.22,3.01,;-1.88,5.11,;-1.88,6.65,;-3.21,7.42,;-4.55,6.65,;-5.88,7.42,;-7.22,6.65,;-8.55,7.42,;-7.22,5.11,;-4.55,5.11,;-5.88,4.34,;-3.21,4.34,;-3.21,2.8,;-1.88,2.03,;-.42,2.51,;.49,1.26,;1.82,.49,;1.82,-1.05,;2.91,-2.14,;2.51,-3.63,;3.6,-4.71,;5.09,-4.32,;5.49,-2.83,;4.4,-1.74,;6.18,-5.4,;7.64,-4.93,;8.55,-6.17,;7.64,-7.42,;6.18,-6.94,;-.42,.01,;-1.88,.49,;-3.21,-.28,;-4.55,.49,;-5.88,-.28,;-4.55,2.03,;-5.88,2.8,;2.03,1.26,;2.8,-.07,;4.34,-.07,;5.11,1.26,;4.34,2.59,;2.8,2.59,)|	InChI=1S/C30H27ClF4N6O3/c31-26-21(32)12-23-20(24(26)25-19(28(36)42)10-11-22(27(25)33)43-29(34)35)13-30(44-23,16-4-2-1-3-5-16)14-37-17-6-8-18(9-7-17)41-15-38-39-40-41/h1-5,10-12,15,17-18,29,37H,6-9,13-14H2,(H2,36,42)	CHGCUBMJGFLUEW-UHFFFAOYSA-N	695348	US12083101, Example 79	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695348	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695348&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444129	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@H]3C[C@H](COC(F)F)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.39,20.20,wD:22.23,(.6,3.78,;-.73,3.01,;.04,1.68,;-2.06,3.78,;-2.06,5.32,;-3.4,6.09,;-4.73,5.32,;-6.06,6.09,;-7.4,5.32,;-8.73,6.09,;-7.4,3.78,;-4.73,3.78,;-6.06,3.01,;-3.4,3.01,;-3.4,1.47,;-2.06,.7,;-.6,1.18,;.31,-.07,;1.64,-.84,;1.64,-2.38,;2.73,-3.47,;4.27,-3.47,;4.27,-5,;5.36,-6.09,;6.85,-5.7,;7.24,-4.21,;8.73,-3.81,;6.16,-3.12,;2.73,-5,;-.6,-1.31,;-2.06,-.84,;-3.4,-1.61,;-4.73,-.8			695349	US12083101, Example 80	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 14.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695349	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695349&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444130	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@H]3CC[C@@H](O)[C@H](F)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.38,20.20,23.24,wD:25.26,(1.97,4.5,;.64,3.73,;1.41,2.4,;-.7,4.5,;-.7,6.04,;-2.03,6.81,;-3.36,6.04,;-4.7,6.81,;-6.03,6.04,;-7.36,6.81,;-6.03,4.5,;-3.36,4.5,;-4.7,3.73,;-2.03,3.73,;-2.03,2.19,;-.7,1.42,;.77,1.9,;1.67,.65,;3.01,-.12,;3.01,-1.66,;4.1,-2.75,;5.58,-2.35,;6.67,-3.44,;6.27,-4.93,;7.36,-6.01,;4.79,-5.32,;4.39,-6.81,;3.7,-4.23,;.77,-.59,;-.7,-.12,;-2.03,-.89,;-3.36,-.12,;-4.7,-.89,;-3.36,1.42,;-4.7,2.19,;3.21,.65,;3.98,-.68,;5.52,-.68,;6.29,.65,;5.52,1			695350	US12083101, Example 81b::US12083101, Example 81a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 33.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695350	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695350&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444131	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@H]3CC[C@@H](O)[C@H](F)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.38,20.20,23.24,wD:25.26,(1.97,4.5,;.64,3.73,;1.41,2.4,;-.7,4.5,;-.7,6.04,;-2.03,6.81,;-3.36,6.04,;-4.7,6.81,;-6.03,6.04,;-7.36,6.81,;-6.03,4.5,;-3.36,4.5,;-4.7,3.73,;-2.03,3.73,;-2.03,2.19,;-.7,1.42,;.77,1.9,;1.67,.65,;3.01,-.12,;3.01,-1.66,;4.1,-2.75,;5.58,-2.35,;6.67,-3.44,;6.27,-4.93,;7.36,-6.01,;4.79,-5.32,;4.39,-6.81,;3.7,-4.23,;.77,-.59,;-.7,-.12,;-2.03,-.89,;-3.36,-.12,;-4.7,-.89,;-3.36,1.42,;-4.7,2.19,;3.21,.65,;3.98,-.68,;5.52,-.68,;6.29,.65,;5.52,1			695350	US12083101, Example 81b::US12083101, Example 81a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 32.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695350	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695350&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444132	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@H]3C[C@H](F)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.35,20.20,wD:22.23,(2.29,3.78,;.96,3.01,;1.73,1.68,;-.38,3.78,;-.38,5.32,;-1.71,6.09,;-3.04,5.32,;-4.38,6.09,;-5.71,5.32,;-7.04,6.09,;-5.71,3.78,;-3.04,3.78,;-4.38,3.01,;-1.71,3.01,;-1.71,1.47,;-.38,.7,;1.09,1.18,;1.99,-.07,;3.33,-.84,;3.33,-2.38,;4.42,-3.47,;5.96,-3.47,;5.96,-5,;7.04,-6.09,;4.42,-5,;1.09,-1.31,;-.38,-.84,;-1.71,-1.61,;-3.04,-.84,;-4.38,-1.61,;-3.04,.7,;-4.38,1.47,;3.53,-.07,;4.3,-1.4,;5.84,-1.4,;6.61,-.07,;5.84,1.27,;4.3,1.27,)|	InChI=1S/C27H22ClF5N2O3/c28-23-18(30)10-20-17(21(23)22-16(25(34)36)6-7-19(24(22)31)37-26(32)33)11-27(38-20,13-4-2-1-3-5-13)12-35-15-8-14(29)9-15/h1-7,10,14-15,26,35H,8-9,11-12H2,(H2,34,36)	HHGWPRNRKZCQJG-UHFFFAOYSA-N	695352	US12083101, Example 82	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 119							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695352	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695352&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444133	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CN[C@@H]3CCC[C@H](O)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.37,20.20,24.25,(1.9,3.89,;.56,3.12,;1.33,1.79,;-.77,3.89,;-.77,5.43,;-2.11,6.2,;-3.44,5.43,;-4.77,6.2,;-6.11,5.43,;-7.44,6.2,;-6.11,3.89,;-3.44,3.89,;-4.77,3.12,;-2.11,3.12,;-2.11,1.58,;-.77,.81,;.69,1.29,;1.6,.04,;2.69,-1.05,;2.			695353	US12083101, Example 83	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 24.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695353	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695353&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444134	C[C@@]1(CC[C@H](O)CC1)NC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:10.38,1.8,wD:1.0,4.4,(4.17,-1.79,;3.78,-3.28,;5.26,-2.88,;6.35,-3.97,;5.95,-5.46,;7.04,-6.55,;4.47,-5.86,;3.38,-4.77,;2.69,-2.19,;3.09,-.7,;2,.39,;1.09,1.63,;-.37,1.16,;-.37,-.38,;1.09,-.86,;-1.71,-1.15,;-3.04,-.38,;-4.37,-1.15,;-3.04,1.16,;-4.37,1.93,;-1.71,1.93,;-1.71,3.47,;-3.04,4.24,;-4.37,3.47,;-3.04,5			695354	US12083101, Example 84	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 41.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695354	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695354&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444135	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNC3CC4(CC(O)C4)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.39,(1.84,13.93,;.51,13.16,;1.28,11.83,;-.82,13.93,;-.82,15.47,;-2.16,16.24,;-3.49,15.47,;-4.83,16.24,;-6.16,15.47,;-7.49,16.24,;-6.16,13.93,;-3.49,13.93,;-4.83,13.16,;-2.16,13.16,;-2.16,11.62,;-.82,10.85,;.64,11.33,;1.55,10.08,;2.63,			695355	US12083101, Example 85a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695355	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695355&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444136	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@@](CNC3CC4(CC(O)C4)C3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wD:17.39,(1.84,13.93,;.51,13.16,;1.28,11.83,;-.82,13.93,;-.82,15.47,;-2.16,16.24,;-3.49,15.47,;-4.83,16.24,;-6.16,15.47,;-7.49,16.24,;-6.16,13.93,;-3.49,13.93,;-4.83,13.16,;-2.16,13.16,;-2.16,11.62,;-.82,10.85,;.64,11.33,;1.55,10.08,;2.63,8.99,;2.24,7.51,;3.32,6.42,;3.32,4.88,;4.86,4.88,;4.86,3.34,;6.4,3.34,;7.49,2.2			695356	US12083101, Example 85b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695356	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695356&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444137	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:16.27,wD:14.15,(-6.16,3.6,;-4.83,4.37,;-3.49,3.6,;-2.16,4.37,;-.83,3.6,;-.83,2.06,;.51,1.29,;1.84,2.06,;-.26,-.05,;-2.16,1.29,;-3.49,2.06,;-4.83,1.29,;-2.16,-.25,;-.83,-1.02,;.64,-.55,;1.97,.22,;1.54,-1.79,;2.63,-2.88,;2.23,-4.37,;.64,-3.04,;-.83,-2.56			695357	US12083101, Example 86	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695357	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695357&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444138	NC[C@@]1(Oc2ccc(Cl)c(c2[C@@H]1O)-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:2.29,wD:11.13,(3.54,-4.23,;3.54,-2.69,;2.21,-1.93,;1.3,-3.17,;-.16,-2.69,;-1.49,-3.47,;-2.83,-2.69,;-2.83,-1.15,;-4.16,-.38,;-1.49,-.38,;-.16,-1.15,;1.3,-.68,;2.64,.09,;-1.49,1.15,;-2.83,1.93,;-4.16,1.15,;-2.83,3.47,;-4.16,4.23,;-5.5,3.47,;-6.83,4.23,;-5.5,1.93,;-1.49,4.23,;-.16,3.47,;-.16,1.93,;1.17,1.15,;2.51,1.93,;.08,.07,;3.75,-1.93,;4.52,-3.26,;6.06,-3.26,;6.83,-1.93,;6.06,-.59,;4.52,-.59,)|	InChI=1S/C23H18ClF3N2O4/c24-13-7-9-14-18(20(30)23(10-28,33-14)11-4-2-1-3-5-11)17(13)16-12(21(29)31)6-8-15(19(16)25)32-22(26)27/h1-9,20,22,30H,10,28H2,(H2,29,31)	ZBHWZFXFMHJNBH-UHFFFAOYSA-N	695358	US12083101, Example 87	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 30.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695358	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695358&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444139	COCCOc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2ccc1Cl)c1ccccc1 |r,wU:19.30,wD:17.18,(-8.16,4.23,;-6.83,3.47,;-5.5,4.23,;-4.16,3.47,;-2.83,4.23,;-1.49,3.47,;-.			695359	US12083101, Example 88	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695359	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695359&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444140	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2ccc1Cl)c1ccccn1 |r,wU:16.27,wD:14.15,(-6.16,3.6,;-4.83,4.37,;-3.49,3.6,;-2.16,4.37,;-.83,3.6,;-.83,2.06,;.51,1.29,;1.84,2.06,;-.26,-.05,;-2.16,1.29,;-3.49,2.06,;-4.83,1.29,;-2.16,-.25,;-.83,-1.02,;.64,-.55,;1.97,.22,;1.54,-1.79,;2.63,-2.88,;2.23,-4.37,;.64,-3.04,;-.83,-2.56,;-2.16,-3.33,;-3.49,-2.56,;-3.49,-1.02,;-4.83,-.25,;3.08,-1.79,;3.85,-.46,;5.39,-.46,;6.16,-1.79,;5.39,-3.13,;3.85,-3.13,)|	InChI=1S/C22H19ClFN3O4/c1-30-14-7-5-11(21(26)29)16(19(14)24)17-12(23)6-8-13-18(17)20(28)22(10-25,31-13)15-4-2-3-9-27-15/h2-9,20,28H,10,25H2,1H3,(H2,26,29)	GRYPOWCKIQXHQU-UHFFFAOYSA-N	695360	US12083101, Example 89	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 19.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695360	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695360&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444141	COc1cccc(n1)[C@@]1(CN)Oc2ccc(Cl)c(c2[C@@H]1O)-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:8.			695361	US12083101, Example 90	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 22.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695361	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695361&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444142	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2ccc1Cl)c1cccnc1OC |r,wU:16.27,wD:1			695362	US12083101, Example 91	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 22.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695362	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695362&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444143	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2ccc1Cl)c1ccc[nH]c1=O |r,wU:16.27,wD:14.15,(-6.16,3.64,;-4.83,4.41,;-3.49,3.64,;-2.16,4.41,;-.83,3.64,;-.83,2.1,;.5			695363	US12083101, Example 92	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 22.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695363	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695363&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444144	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2ccc1Cl)c1ccccc1OC(F)(F)F |r,wU:16.27,wD:14.15,(-6.16,4.98,;-4.83,5.75,;-3.49,4.98,;-2.16,5.75,;-.83,4.98,;-.83,3.4			695364	US12083101, Example 93	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 9.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695364	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695364&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444145	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2[C@H](O)[C@](CN[C@H]3CC[C@H](O)CC3)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.37,21.21,wD:16.17,24.25,(1.8,11.54,;.47,10.77,;-.3,9.44,;-.86,11.5			695365	US12083101, Example 94a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695365	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695365&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444146	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2[C@H](O)[C@](CN[C@@H]3CC[C@H](O)CC3)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.37,21.21,24.25,wD:16.17,(1.8,11.54,;.47,10.77,;-.3,9.44,;-.86,11.54,;-.86,13.08,;-2.2,13.85,;-3.53,13.08,;-4.86,13.85,;-6.2,13.08,;-7.53,13.85,;-			695366	US12083101, Example 94b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695366	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695366&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444147	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN[C@H]3CC[C@H](O)CC3)(Oc2ccc1Cl)c1ccccn1 |r,wU:16.35,19.19,wD:14.15,22.23,(-6.86,13.08,;-5.52,13.85,;-4.19,13.08,;-2.86,			695367	US12083101, Example 95a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 8.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695367	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695367&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444148	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN[C@@H]3CC[C@H](O)CC3)(Oc2ccc1Cl)c1ccccn1 |r,wU:16.35,19.19,22.23,wD:14.15,(-6.86,13.08,;-5.52,13.85,;-4.19,13.08,;-2.86			695368	US12083101, Example 95b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695368	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695368&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444149	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2[C@H](O)[C@](CNC3CCC3)(Oc2ccc1Cl)c1ccccc1 |r,wU:18.34,wD:16.17,(2.51,3.37,;1.17,2.6,;.4,1.27,;-.16,3.37,;-.16,4.91,;-1.49,5.68,;-2			695369	US12083101, Example 96	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695369	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695369&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444150	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:16.28,wD:			695370	US12083101, Example 97	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695370	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695370&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444151	NC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1O)-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:2.30,wD:12.14,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-3.04,;.51,-2.56,;-.83,-3.33,			695371	US12083101, Example 98	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695371	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695371&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444152	NC(=O)c1ccc(OCCO)c(F)c1-c1c2[C@H](O)[C@](CNC3CCC3)(Oc2cc(F)c1Cl)c1ccccc1 |wD:16.17,18.19,(-2.67,-3.08,;-1.33,-2.31,;-2.24,-1.06,;,-3.08,;,-4.62,;1.33,-5.39,;2.67,-4.62,;4,-5.39,;4,-6.93,;2.67,-7.7,;2.67,-9.24,;2.67,-3.08,;4,-2.31,;1.33,-2.3			695372	US12083101, Example 99	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695372	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695372&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444153	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2[C@H](O)[C@](CN[C@H]3CC[C@H](O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.38,21.21,wD:16.17,24.25,(1.8,12.5,;.47,11.73,;-.3,10.4,;-.86,12.5,;-.86,14.04,;-2.2,14.81,;-3.53,14.04,;-4.86,14.81,;-6.2,14.04,;-7.53,14.81,;-			695373	US12083101, Example 100a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695373	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695373&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444154	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2[C@H](O)[C@](CN[C@@H]3CC[C@H](O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.38,21.21,24.25,wD:16.17,(1.8,12.5,;.47,11.73,;-.3,10.4,;-.86,12.5,;-.86,14.04,;-2.2,14.81,;-3.53,14.04,;-4.86,14.81,;-6.2,14.04,;-7.53,14.81,;-6.2,12.5,;-3.53,12.5,;-4.86,11.73,;-2.2,11.73,;-2.2,10.19,;-.86,9.42,;.6,9.9,;1.93,10.67,;1.51,8.65,;2.6,7.56,;2.2,6.07,;3.53,5.3,;3.53,3.76,;4.86,2.99,;6.2,3.76,;7.53,2.99,;6.2,5.3,;4.86,6.07,;.6,7.41,;-.86,7.88,;-2.2,7.11,;-3.53,7.88,;-4.86,7.11,;-3.53,9.42,;-4.86,10.19,;3.05,8.65,;3.82,7.32,;5.36,7.32,;6.13,8.65,;5.36,9.98,;3.82,9.98,)|	InChI=1S/C29H27ClF4N2O5/c30-24-18(31)12-20-22(23(24)21-17(27(35)39)10-11-19(25(21)32)40-28(33)34)26(38)29(41-20,14-4-2-1-3-5-14)13-36-15-6-8-16(37)9-7-15/h1-5,10-12,15-16,26,28,36-38H,6-9,13H2,(H2,35,39)	YRCXKPJVFPYNNS-UHFFFAOYSA-N	695374	US12083101, Example 100b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695374	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695374&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444155	NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:2.28,(3.57,-4.37,;3.96,-2.88,;2.88,-1.79,;1.97,-.55,;.51,-1.02,;.51,-2.56,;1.97,-3.04,;-.83,-3.33,;-2.16,-2.56,;-2.16,-1.02,;-3.49,-.25,;-.83,-.25,;-.83,1.29,;-2.16,2.06,;-3.49,1.29,;-2.16,3.6,;-3.49,4.37,;-4.83,3.6,;-6.16,4.37,;-7.5,3.6,;-.83,4.37,;.51,3.6,;.51,2.06,;1.84,1.29,;3.17,2.06,;2.61,-.05,;4.42,-1.79,;5.19,-3.13,;6.73,-3.13,;7.5,-1.79,;6.73,-.46,;5.19,-.46,)|	InChI=1S/C24H22ClFN2O4/c25-17-7-9-18-16(12-24(13-27,32-18)14-4-2-1-3-5-14)20(17)21-15(23(28)30)6-8-19(22(21)26)31-11-10-29/h1-9,29H,10-13,27H2,(H2,28,30)	CXZFQTJAXWOQAP-UHFFFAOYSA-N	695261	US12083101, Example 10	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695261&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444156	CO[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@H](O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:6.17,9.9,wD:2.1,12.13,(3.42,11.07,;1.93,10.67,;.6,9.9,;-.86,9.42,			695375	US12083101, Example 102a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695375	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695375&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444157	CO[C@H]1c2c(O[C@]1(CN[C@@H]1CC[C@H](O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O	InChI=1S/C30H29ClF4N2O5/c1-40-27-23-21(42-30(27,15-5-3-2-4-6-15)14-37-16-7-9-17(38)10-8-16)13-19(32)25(31)24(23)22-18(28(36)39)11-12-20(26(22)33)41-29(34)35/h2-6,11-13,16-17,27,29,37-38H,7-10,14H2,1H3,(H2,36,39)	GDXBHRZMUNXGTC-UHFFFAOYSA-N	695376	US12083101, Example 102b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695376	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695376&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444158	C[C@H]1c2c(O[C@]1(CN)c1ccccc1)ccc(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:5.8,wD:1			695377	US12083101, Example 103	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695377	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695377&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444159	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@@](C)(O)CC1)c1ccccc1)ccc(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O	InChI=1S/C31H32ClF3N2O4/c1-17-24-22(11-9-21(32)26(24)25-20(28(36)38)8-10-23(27(25)33)40-29(34)35)41-31(17,18-6-4-3-5-7-18)16-37-19-12-14-30(2,39)15-13-19/h3-11,17,19,29,37,39H,12-16H2,1-2H3,(H2,36,38)	POHGVUUUPOPEDN-UHFFFAOYSA-N	695378	US12083101, Example 104a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695378	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695378&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444160	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@](C)(O)CC1)c1ccccc1)ccc(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:5.17,8.8,11.12,wD:1.0,11.13,(1.27,10.82,;.18,9.73,;-1.29,9.26,;-1.2			695379	US12083101, Example 104b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695379	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695379&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444161	C[C@H]1c2c(O[C@]1(CN)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:5.8,wD:1.0,(2.64,.22,;1.3,-.55,;-.16,-1.02,;-.16,-2.56,;1.3,-3.04,;2.21,-1.79,;3.3,-2.88,;2.9,-4.37,;3.75,-1.79,;4.52,-3.13,;6.06,-3.13,;6.83,-1.79,;6.06,-.46,;4.52,-.46,;-1.49,-3.33,;-2.83,-2.56,;-4.16,-3.33,;-2.83,-1.02,;-4.16,-.25,;-1.49,-.25,;-1.49,1.29,;-2.83,2.06,;-4.16,1.29,;-2.83,3.6,;-4.16,4.37,;-5.5,3.6,;-6.83,4.37,;-5.5,2.06,;-1.49,4.37,;-.16,3.6,;-.16,2.06,;1.17,1.29,;2.51,2.06,;.4,-.05,)|	InChI=1S/C24H19ClF4N2O3/c1-11-17-16(34-24(11,10-30)12-5-3-2-4-6-12)9-14(26)20(25)19(17)18-13(22(31)32)7-8-15(21(18)27)33-23(28)29/h2-9,11,23H,10,30H2,1H3,(H2,31,32)	ABXKXQPTAATFJL-UHFFFAOYSA-N	695380	US12083101, Example 105	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695380	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695380&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444162	COCCOc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wD:17.18,19.20,(6.67,4.24,;5.34,3.47,;4,4.24,;2.67,3.47,;1.33,4.24,;0,3.47,;-1.33,4.24,;-2.67,3.47,;-2.67,1.93,;-4.13,1.45,;-5.28,2.48,;-4.45,-.06,;-1.33,1.16,;0,1.93,;1.33,1.16,;-1.33,-.38,;-0,-1.15,;1.46,-.68,;1.86,.81,;2.36,-1.92,;3.7,-2.7,;3.7,-4.24,;1.46,-3.17,;-0,-2.69,;-1.34,-3.46,;-2.67,-2.7,;-4,-3.47,;-2.67,-1.16,;-4.01,-.39,;3.7,-1.16,;3.7,.38,;5.04,1.15,;6.37,.38,;6.37,-1.16,;5.03,-1.93,)|	InChI=1S/C26H25ClF2N2O4/c1-14-20-19(35-26(14,13-30)15-6-4-3-5-7-15)12-17(28)23(27)22(20)21-16(25(31)32)8-9-18(24(21)29)34-11-10-33-2/h3-9,12,14H,10-11,13,30H2,1-2H3,(H2,31,32)	STUFJDNPXWLGBO-UHFFFAOYSA-N	50626283	US12083101, Example 106::CHEMBL5400107	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		<1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50626283	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50626283&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search			160935238	505044255							3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444163	C[C@H]1c2c(O[C@]1(CN)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O |r,wU:5.8,wD:1.0,(3.37,.27,;2.28,-.82,;.82,-1.3,;.82,-2.84,;2.28,-3.31,;3.19,-2.07,;4.52,-2.84,;4.52,-4.38,;4.52,-1.3,;5.85,-2.07,;7.19,-1.3,;7.19,.24,;5.85,1.01,;4.52,.24,;-.52,-3.61,;-1.85,-2.84,;-3.19,-3.61,;-1.85,-1.3,;-3.19,-.53,;-.52,-.53,;-.52,1.3,;-1.85,2.07,;-3.19,1.3,;-1.85,3.61,;-3.19,4.38,;-4.52,3.61,;-5.85,4.38,;-7.19,3.61,;-.52,4.38,;.82,3.61,;.82,2.07,;2.15,1.3,;3.48,2.07,;2.15,-.24,)|	InChI=1S/C25H23ClF2N2O4/c1-13-19-18(34-25(13,12-29)14-5-3-2-4-6-14)11-16(27)22(26)21(19)20-15(24(30)32)7-8-17(23(20)28)33-10-9-31/h2-8,11,13,31H,9-10,12,29H2,1H3,(H2,30,32)	CUHXUWVGBSAUMT-UHFFFAOYSA-N	695382	US12083101, Example 107	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695382	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695382&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444164	COCCOc1ncc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.31,			695383	US12083101, Example 108	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695383	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695383&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444165	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN)(Oc2cc(F)c1Cl)c1ccccn1 |r,wU:16.28,wD:14.15,(-5.85,3.75,;-4.52,4.52,;-3.19,3.75,;-1.85,4.52,;-.52,3.75,;-.52,2.21,;.82,1.44,;2.15,2.21,;.82,-.1,;-1.85,1.44,;-3.19,2.21,;-4.52,1.44,;-1.85,-.67,;-.52,-1.44,;.95,-.97,;2.04,.12,;1.85,-2.21,;3.19,-2.98,;3.19,-4.52,;.95,-3.46,;-.52,-2.98,;-1.85,-3.75,;-3.19,-2.98,;-4.52,-3.75,;-3.19,-1.44,;-4.52,-.67,;3.19,-1.44,;3.19,.1,;4.52,.87,;5.85,.1,;5.85,-1.44,;4.52,-2.21,)|	InChI=1S/C23H20ClF2N3O3/c1-11-17-15(32-23(11,10-27)16-5-3-4-8-29-16)9-13(25)20(24)19(17)18-12(22(28)30)6-7-14(31-2)21(18)26/h3-9,11H,10,27H2,1-2H3,(H2,28,30)	WGBWBDGJDGJAFB-UHFFFAOYSA-N	695384	US12083101, Example 109	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695384	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695384&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444166	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:3.31			695385	US12083101, Example 110	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695385	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695385&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444167	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OCCOC)ccc1C(N)=O)c1ccccn1 |r,wU:3.3			695386	US12083101, Example 111	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695386	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695386&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444168	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccn1 |r,wU:3.31			695387	US12083101, Example 112	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695387	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695387&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444169	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OCCO)ccc1C(=O)NC)c1ccccc1 |r,wU:3.3			695388	US12083101, Example 113	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695388	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695388&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444170	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1	InChI=1S/C33H37ClF2N2O5/c1-18(39)16-42-24-10-9-22(31(37)40)27(30(24)36)28-26-19(2)33(20-7-5-4-6-8-20,43-25(26)15-23(35)29(28)34)17-38-21-11-13-32(3,41)14-12-21/h4-10,15,18-19,21,38-39,41H,11-14,16-17H2,1-3H3,(H2,37,40)	CVBOSVNZASLNIM-UHFFFAOYSA-N	695389	US12083101, Example 114a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695389	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695389&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444171	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.40,22.22,25.27,wD:1.1,17.18,25.26,(-7.93,5.21,;-6.6,5.98,;-6.6,7.52,;-5.27,5.21,;-3.93,5.98,;-2.6,5.21,;-1.27,5.98,;.07,5.21,;.07,3.67,;1.4,2.9,;2.73,3.67,;.63,1.56,;-1.27,2.9,;-2.6,3.67,;-3.93,2.9,;-1.27,1.36,;.07,.59,;1.53,1.06,;2.62,2.15,;2.44,-.18,;3.53,-1.27,;3.13,-2.76,;4.22,-3.85,;5.7,-3.45,;6.79,-4.54,;6.39,-6.03,;7.93,-6.03,;6.79,-7.52,;4.91,-6.43,;3.82,-5.34,;1.53,-1.43,;.07,-.95,;-1.27,-1.72,;-2.6,-.95,;-3.93,-1.72,;-2.6,.59,;-3.93,1.36,;3.98,-.18,;4.75,-1.52,;6.29,-1.52,;7.06,-.18,;6.29,1.15,;4.75,1.15,)|	InChI=1S/C33H37ClF2N2O5/c1-18(39)16-42-24-10-9-22(31(37)40)27(30(24)36)28-26-19(2)33(20-7-5-4-6-8-20,43-25(26)15-23(35)29(28)34)17-38-21-11-13-32(3,41)14-12-21/h4-10,15,18-19,21,38-39,41H,11-14,16-17H2,1-3H3,(H2,37,40)	CVBOSVNZASLNIM-UHFFFAOYSA-N	695390	US12083101, Example 114b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695390	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695390&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444172	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@H](O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:5.16,8.8,wD:1.0,11.12,(1.37,1.81,;.28,.72,;-1.18,.24,;-1.18,-1.3,;.28,-1.77,;1.18,-.53,;2.52,-1.3,;2.52,-2.84,;3.85,-3.61,;5.19,-2.84,;6.52,-3.61,;6.52,-5.15,;7.85,-5.92,;5.19,-5.92,;3.85,-5.15,;2.52,.24,;3.85,-.53,;5.19,.24,;5.19,1.78,;3.85,2.55,;2.52,1.78,;-2.52,-2.07,;-3.85,-1.3,;-5.19,-2.07,;-3.85,.24,;-5.19,1.01,;-2.52,1.01,;-2.52,2.84,;-3.85,3.61,;-5.19,2.84,;-3.85,5.15,;-5.19,			695391	US12083101, Example 115a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695391	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695391&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444173	C[C@H]1c2c(O[C@]1(CN[C@@H]1CC[C@H](O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O |r,wU:5.16,8.8,11.12,wD:1.0,(1.37,1.81,;.28,.72,;-1.18,.24,;-1.18,-1.3,;.28,-1.77,;1.18,-.53,;2.52,-1.3,;2.52,-2.84,;3.85,-3.61,;3.85,-5.15,;5.19,-5.92,;6.52,-5.15,;7.85,-5.92,;6.52,-3.61,;5.19,-2.84,;2.52,.24,;3.85,-.53,;5.19,.24,;5.19,1.78,;3.85,2.55,;2.52,1.78,;-2.52,-2.07,;-3.85,-1.3,;-5.19,-2.07,;-3.85,.24,;-5.19,1.01,;-2.52,1.01,;-2.52,2.84,;-3.85,3.61,;-5.19,2.84,;-3.85,5.15,;-5.19,5.92,;-6.52,5.15,;-7.85,5.92,;-6.52,3.61,;-2.52,5.92,;-1.18,5.15,;-1.18,3.61,;.			695392	US12083101, Example 115b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695392	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695392&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444174	COCCOc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.40,25.27,wD:17.18,22.22,25.26,(-9.29,6.2,;-7.96,5.43,;-6.62,6.2,;-5.29,5.43,;-3.96,6.2,;-2.62,5.43,;-1.29,6.2,;.05,5.43,;.05,3.89,;1.38,3.12,;2.71,3.89,;1.38,1.58,;-1.29,3.12,;-2.62,3.89,;-3.96,3.12,;-1.29,1.29,;.05,.52,;1.51,1,;2.6,2.09,;2.42,-.25,;3.75,-1.02,;3.75,-2.56,;5.08,-3.33,;5.08,-4.87,;6.42			695393	US12083101, Example 116a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		<1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695393	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695393&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444175	COCCOc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.40,22.22,25.27,wD:17.18,25.26,(-9.29,6.2,;-7.96,5.43,;-6.62,6.2,;-5.29,5.43,;-3.96,6.2,;-2.62,5.43,;-1.29,6.2,;.05,5.43,;.05,3.89,;1.38,3.12,;2.71,3.89,;1.38,1.58,;-1.29,3.12,;-2.62,3.89,;-3.96,3.12,;-1.29,1.29,;.05,.52,;1.51,1,;2.6,2.09,;2.42,-.25,;3.75,-1.02,;3.75,-2.56,;5.08,-3.33,;6.42,-2.56,;7.75,-3.33,;7.75,-4.87,;8.52,-6.2,;9.29,-4.87,;6.42,-5.64,;5.08,-4.87,;1.51,-1.49,;.05,-1.02,;-1.29,-1.79,;-2.62,-1.02,;-3.96,-1.79,;-2.62,.52,;-3.96,1.29,;3.75,.52,;5.08,-.25,;6.42,.52,;6.42,2.06,;5.08,2.83,;3.75,2.06,)|	InChI=1S/C33H37ClF2N2O5/c1-19-26-25(43-33(19,20-7-5-4-6-8-20)18-38-21-11-13-32(2,40)14-12-21)17-23(35)29(34)28(26)27-22(31(37)39)9-10-24(30(27)36)42-16-15-41-3/h4-10,17,19,21,38,40H,11-16,18H2,1-3H3,(H2,37,39)	CXBYOLIVXSYAPB-UHFFFAOYSA-N	695394	US12083101, Example 116b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695394	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695394&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444176	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@](C)(O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O |r,wU:5.17,8.8,11.12,wD:1.0,11.13,(1.93,2.09,;.84,1,;-.62,.52,;-.62,-1.0			695395	US12083101, Example 117a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		<1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695395	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695395&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444177	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@@](C)(O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O	InChI=1S/C32H35ClF2N2O5/c1-18-25-24(42-32(18,19-6-4-3-5-7-19)17-37-20-10-12-31(2,40)13-11-20)16-22(34)28(33)27(25)26-21(30(36)39)8-9-23(29(26)35)41-15-14-38/h3-9,16,18,20,37-38,40H,10-15,17H2,1-2H3,(H2,36,39)	AGWHAXIUQHVAMF-UHFFFAOYSA-N	695396	US12083101, Example 117b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695396	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695396&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444178	C[C@H]1c2c(O[C@]1(CNC1CCC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O |r,wU:5.13,wD:1.0,(3.09,1.4,;2,.31,;.54,-.17,;.54,-1.71,;2,-2.18,;2.91,-.94,;4.24,-1.71,;4.24,-3.25,;5.58,-4.02,;5.98,-5.51,;7.46,-5.11,;7.06,-3.62,;4.24,-.17,;5.58,-.94,;6.91,-.17,;6.91,1.37,;5.58,2.14,;4.24,1.37,;-.79,-2.48,;-2.13,-1.71,;-3.46,-2.48,;-2.13,-.17,;-3.46,.6,;-.79,.6,;-.79,2.43,;-2.13,3.2,;-3.46,2.43,;-2.13,4.74,;-3.46,5.51,;-4.8,4.74,;-6.13,5.51,;-7.46,4.74,;-.79,5.51,;.54,4.74,;.54,3.2,;1.87,2.43,;3.21,3.2,;1.87,.89,)|	InChI=1S/C29H29ClF2N2O4/c1-16-23-22(38-29(16,15-34-18-8-5-9-18)17-6-3-2-4-7-17)14-20(31)26(30)25(23)24-19(28(33)36)10-11-21(27(24)32)37-13-12-35/h2-4,6-7,10-11,14,16,18,34-35H,5,8-9,12-13,15H2,1H3,(H2,33,36)	LGULRZFIQKEVKO-UHFFFAOYSA-N	695397	US12083101, Example 118	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695397	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695397&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444179	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@](C)(O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ncc1C(N)=O |r,wU:5.17,8.8,11.12,wD:1.0,11.13,(3.61,3.2,;2.28,2.43,;.82,1.95,;.82,.41,;2.28,-.06,;3.19,1.18,;3.58,-.3,;2.49,-1.39,;2.89,-2.88,;4.38,-3.28,;4.78,-4.77,;3.69,-5.86,;5.18,-6.25,;4.09,-7.34,;2.2,-5.46,;1.8,-3.97,;4.52,1.95,;5.85,1.18,;7.19,1.95,;7.19,3.49,;5.85,4.26,;4.52,3.49,;-.52,-.36,;-1.85,.41,;-3.19,-.36,;-1.85,1.95,;-3.19,2.72,;-.52,2.72,;-.52,4.26,;-1.85,5.03,;-3.19,4.26,;-1.85,6.57,;-3.19,7.34,;-4.52,6.57,;-5.85,7.34,;-7.19,6.57,;-.52,7.34,;.82,6.57,;.82,5.03,;2.15,4.26,;3.48,5.03,;1.38,2.93,)|	InChI=1S/C31H34ClF2N3O5/c1-17-23-22(42-31(17,18-6-4-3-5-7-18)16-37-19-8-10-30(2,40)11-9-19)14-21(33)26(32)25(23)24-20(28(35)39)15-36-29(27(24)34)41-13-12-38/h3-7,14-15,17,19,37-38,40H,8-13,16H2,1-2H3,(H2,35,39)	ABPBQTNEJUXUEY-UHFFFAOYSA-N	695398	US12083101, Example 119	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695398	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695398&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444180	C[C@H](O)COc1ccc(C#N)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.39,21.21,24.25,wD:16.17,24.26,1.1,(-7.19,5.8,;-5.85,6.57,;-5.85,8.11,;-4.52,5.8,;-3.19,6.57,;-1.85,5.8,;-.52,6.57,;.82,5.8,;.82,4.26,;2.36,4.26,;3.9,4.26,;-.52,3.49,;-1.85,4.26,;-3.19,3.49,;-.52,1.95,;.82,1.18,;2.28,1.6			695399	US12083101, Example 120	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695399	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695399&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444181	CNC(=O)c1ccc(OCCO)c(F)c1-c1c2[C@H](C)[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.40,22.22,25.26,wD:17.18,25.27,(4.82,4.26,;3.48,5.03,;2.15,4.26,;1.38,2.93,;.82,5.03,;.82,6.57,;-.52,7.34,;-1.85,6.57,;-3.19,7.34,;-4.52,6.57,;			695400	US12083101, Example 121	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695400	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695400&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444182	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OC[C@H](C)O)ccc1C(=O)NC)c1ccccc1 |r,wU:3.33,wD:21.24,13.15,(4.3,-6.84,;3.21,-5.75,;3.61,-4.26,;2.52,-3.17,;1.61,-4.42,;.15,-3.94,;-1.18,-4.71,;-2.52,-3.94,;-3.85,-4.71,;-2.52,-2.4,;-3.85,-1.63,;-1.18,-1.63,;.15,-2.4,;1.61,-1.93,;1.61,-.39,;-1.18,-.09,;-2.52,.68,;-3.85,-.09,;-2.52,2.22,;-3.85,2.99,;-3.85,4.53,;-5.19,5.3,;-6.52,4.53,;-5.19,6.84,;-1.18,2.99,;.15,2.22,;.15,.68,;1.69,.68,;2.46,-.66,;2.46,2.01,;1.69,3.35,;3.85,-2.4,;5.19,-3.17,;6.52,-2.4,;6.52,-.86,;5.19,-.09,;3.85,-.86,)|	InChI=1S/C28H29ClF2N2O4/c1-15(34)13-36-20-11-10-18(27(35)33-4)23(26(20)31)24-22-16(2)28(14-32-3,17-8-6-5-7-9-17)37-21(22)12-19(30)25(24)29/h5-12,15-16,32,34H,13-14H2,1-4H3,(H,33,35)	PPIKBIXOOPVTGQ-UHFFFAOYSA-N	695401	US12083101, Example 122	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695401	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695401&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444183	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:19.31,wD:1.1,17.18,(-6.52,3.98,;-5.19,4.75,;-5.19,6.29,;-3.85,3.98,;-3.85,2.44,;-2.52,1.67,;-1.18,2.44,;.15,1.67,;.15,.13,;1.69,.13,;2.46,1.47,;2.46,-1.2,;-1.18,-.64,;-2.52,.13,;-3.85,-.64,;-1.18,-2.18,;.15,-2.95,;1.61,-2.47,;1.61,-.93,;2.52,-3.72,;3.61,-4.81,;3.21,-6.29,;1.61,-4.96,;.15,-4.49,;-1.18,-5.26,;-2.52,-4.49,;-3.85,-5.26,;-2.52,-2.95,;-3.85,-2.18,;3.85,-2.95,;5.19,-3.72,;6.52,-2.95,;6.52,-1.41,;5.19,-.64,;3.85,-1.41,)|	InChI=1S/C26H25ClF2N2O4/c1-13(32)11-34-18-9-8-16(25(31)33)21(24(18)29)22-20-14(2)26(12-30,15-6-4-3-5-7-15)35-19(20)10-17(28)23(22)27/h3-10,13-14,32H,11-12,30H2,1-2H3,(H2,31,33)	ARYPIDIYEMKGMQ-UHFFFAOYSA-N	695402	US12083101, Example 123	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695402	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695402&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444184	C[C@H]1c2c(O[C@]1(CN)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(F)ccc1OCCO |r,wU:5.8,wD:1.0,(.28,.82,;.28,-.72,;-1.18,-1.2,;-1.18,-2.74,;.28,-3.22,;1.18,-1.97,;2.27,-3.06,;1.88,-4.55,;2.52,-1.2,;3.85,-1.97,;5.19,-1.2,;5.19,.34,;3.85,1.11,;2.52,.34,;-2.52,-3.51,;-3.85,-2.74,;-5.19,-3.51,;-3.85,-1.2,;-5.19,-.43,;-2.52,-.43,;-2.52,1.11,;-3.85,1.88,;-5.19,1.11,;-3.85,3.42,;-5.19,4.19,;-2.52,4.19,;-1.18,3.42,;-1.18			695403	US12083101, Example 124	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695403	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695403&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444185	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OC)ccc1C(N)=O)c1cccc(O)n1 |r,wU:3.29,wD:13.15,(2.96,-4.91,;1.88,-3.82,;2.27,-2.34,;1.18,-1.25,;.28,-2.49,;-1.18,-2.02,;-2.52,-2.79,;-3.85,-2.02,;-5.19,-2.79,;-3.85,-.48,;-5.19,.29,;-2.52,.29,;-1.18,-.48,;.28,-0,;.28,1.54,;-2.52,1.83,;-3.85,2.6,;-5.19,1.83,;-3.85,4.14,;-5.19,4.91,;-6.52,4.14,;-2.52,4.91,;-1.18,4.14,;-1.18,2.6,;.36,2.6,;1.13,3.94,;1.13,1.27,;2.52,-.48,;2.52,1.06,;3.85,1.83,;5.19,1.06,;5.19,-.48,;6.52,-1.25,;3.85,-1.2			695404	US12083101, Example 125	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695404	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695404&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444186	COCCOc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1ccccn1 |r,wU:19.40,22.22,25.26,wD:17.18,25.27,(-8.58,6.75,;-7.24,5.98,;-5.91,6.75,;-4.57,5.98,;-3.24,6.75,;-1.91,5.98,;-.57,6.75,;.76,5.98,;.76,4.44,;2.3,4.44,;3.07,5.77,;3.07,3.1,;-.57,3.67,;-1.91,4.44,;-3.24,3.67,;-.57,2.13,;.76,1.36,;2.23,1.83,;2.23,3.37,;3.13,.59,;4.22,-.5,;3.82,-1.99,;4.91,-3.08,;6.4,-2.68,;7.49,-3.77,;7.09,-5.26,;7.49,-6.75,;8.58,-5.66,;5.6,-5.66,;4.51,-4.57,;2.23,-.66,;.7			695405	US12083101, Example 126	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695405	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695405&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444187	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2cc(F)c1Cl)c1cccnc1 |r,wU:16.37,19.19,22.23,wD:14.15,22.24,(-6.57,6,;-5.24,6.77,;-3.91,6,;-2.57,6.77,;-1.24,6,;-1.24,4.46,;.3,4.46,;1.07,5.8,;1.07,3.13,;-2.57,3.69,;-3.91,4.46,;-5.24,3.69,;-2.57,2.15,;-1.24,1.38,;.22,1.86,;.22,3.4,;1.13,.61,;2.22,-.48,;1.82,-1.96,;2.91,-3.05,;4.4,-2.66,;5.49,-3.74,;5.09,-5.23,;5.09,-6.77,;6.57,-5.63			695406	US12083101, Example 127	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695406	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695406&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444188	COc1ccc(C(N)=O)c(c1)-c1c2C[C@](CN)(Oc2ccc1C(F)(F)F)c1ccccc1 |r,wU:14.28,(-5.85,3.62,;-4.52,4.39,;-3.19,3.62,;-1.85,4.39,;-.52,3.62,;-.52,2.08,;1.02,2.08,;1.79,3.42,;1.79,.75,;-1.85,1.31,;-3.19,2.08,;-1.85,-.23,;-.52,-1,;.95,-.52,;1.85,-1.77,;2.94,-2.85,;2.94,-4.39,;.95,-3.01,;-.52,-2.54,;-1.85,-3.31,;-3.19,-2.54,;-3.19			695407	US12083101, Example 128	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 176							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695407	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695407&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444189	CNC(=O)c1ccc(OC)c(F)c1-c1c2C[C@](CN[C@H]3CC[C@](C)(O)CC3)(Oc2ccc1C#N)c1ccccc1 |r,wU:16.37,19.19,22.23,wD:22.24,(2.61,5.8,;1.07,5.8,;.3,4.46,;1.07,3.13,;-1.24,4.46,;-1.24,6,;-2.57,6.77,;-3.91,6,;-5.24,6.77,;-6.57,6,;-3.91,4.46,;-5.24,3.69,;-2.57,3.69,;-2.57,2.15,;-1.24,1.38,;.22,1.86,;1.13,.61,;2.22,-.48,;1.82,-1.96,;2.91,-3.05,;4.4,-2.66,;5.49,-3.74,;5.09,-5.23,;5.09,-6.77,;6.57,-5.63,;3.6,-5.63,;2.51,-4.54,;.22,-.63,;-1.24,-.16,;-2.57,-.93,;-3.91,-.16,;-3.91,1.38,;-5.24,2.15			695408	US12083101, Example 129	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 25.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695408	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695408&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444190	O[C@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(C#N)c2-c1ccccc1)c1ccccc1 |r,wU:9.29,4.7,wD:1.0,(4.93,-7.08,;4.16,-5.75,;4.93,-4.41,;4.16,-3.08,;2.62,-3.08,;1.85,-4.41,;2.62,-5.75,;1.85,-1.75,;2.62,-.41,;1.85,.92,;.95,2.17,;-.52,1.69,;-.52,.15,;.95,-.32,;-1.85,-.62,;-3.19,.15,;-3.19,1.69,;-4.52,2.46,;-5.85,3.23,;-1.85,2.46,;-1.85,4,;-.52,4.77,;-.52,6.31,;-1.85,7.08,;-3.19,6.31,;-3.19,4.77,;3.19,1.69,;4.52,			695409	US12083101, Example 130	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 797							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695409	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695409&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444191	NC[C@]1(Cc2c(O1)ncc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:2.24,(1.57,-4.37,;1.96,-2.88,;.88,-1.79,;-.03,-.55,;-1.49,-1.02,;-1.49,-2.56,;-.03,-3.04,;-2.83,-3.33,;-4.16,-2.56,;-4.16,-1.02,;-5.5,-.25,;-2.83,-.25,;-2.83,1.29,;-4.16,2.06,;-5.5,1.29,;-4.16,3.6,;-2.83,4.37,;-1.49,3.6,;-1.45,2.03,;-.11,1.26,;1.22,2.03,;.36,-.2,;2.42,-1.79,;3.19,-3.13,;4.73,-3.13,;5.5,-1.79,;4.73,-.46,;3.19,-.46,)|	InChI=1S/C21H17ClFN3O2/c22-15-10-26-20-14(9-21(11-24,28-20)12-5-2-1-3-6-12)17(15)18-13(19(25)27)7-4-8-16(18)23/h1-8,10H,9,11,24H2,(H2,25,27)	SZVHVEYDHCHHGA-UHFFFAOYSA-N	695410	US12083101, Example 131	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1290							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695410	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695410&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444192	COc1ccc(C(N)=O)c(c1F)-c1c2OC(CN)(Cc2ccc1Cl)c1ccccc1 |(-6.16,3.64,;-4.83,4.41,;-3.49,3.64,;-2.16,4.41,;-.83,3.64,;-.83,2.1,;.51,1.33,;1.84,2.1,;.51,2.87,;-2.16,1.33,;-3.49,2.1,;-4.83,1.33,;-2.16,-.21,;-.83,-.98,;.64,-.5,;1.54,-1.75,;2.31,-3.08,;1.54,-4.41,;.64,-2.99,;-.83,-2.52,;-2.16,-3.29,;-3.49,-2.52,;-3.49,-.98,;-4.83,-.21,;3.08,-1.75,;3.85,-3.08,;5.39,-3.08,;6.16,-1.75,;5.39,-.41,;3.85,-.41,)|	InChI=1S/C23H20ClFN2O3/c1-29-17-10-8-15(22(27)28)18(20(17)25)19-16(24)9-7-13-11-23(12-26,30-21(13)19)14-5-3-2-4-6-14/h2-10H,11-12,26H2,1H3,(H2,27,28)	YIAVXUOSOFSYOW-UHFFFAOYSA-N	695411	US12083101, Example 132	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2080							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695411	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695411&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444193	NCC1(Oc2ccc(Cl)c(c2O1)-c1c(F)cccc1C(N)=O)c1ccccc1 |(2.29,-4.23,;2.29,-2.69,;.95,-1.93,;.05,-3.17,;-1.42,-2.69,;-2.75,-3.47,;-4.08,-2.69,;-4.08,-1.15,;-5.42,-.38,;-2.75,-.38,;-1.42,-1.15,;.05,-.68,;-2.75,1.15,;-4.08,1.93,;-5.42,1.15,;-4.08,3.47,;-2.75,4.23,;-1.42,3.47,;-1.37,1.9,;-.03,1.13,;1.3,1.9,;.44,-.34,;2.44,-1.53,;3.53,-2.62,;5.02,-2.22,;5.42,-.73,;4.33,.36,;2.84,-.04,)|	InChI=1S/C21H16ClFN2O3/c22-14-9-10-16-19(18(14)17-13(20(25)26)7-4-8-15(17)23)28-21(11-24,27-16)12-5-2-1-3-6-12/h1-10H,11,24H2,(H2,25,26)	HUNAIPLAYYXRPR-UHFFFAOYSA-N	695412	US12083101, Example 133	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 695							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695412	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695412&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444194	NC[C@]1(Cc2c(N1)cc(F)c(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:2.25,(2.84,-4.05,;2.84,-2.51,;1.35,-2.11,;.45,-.86,;-1.02,-1.34,;-1.02,-2.88,;.45,-3.36,;-2.35,-3.65,;-3.68,-2.88,;-5.02,-3.65,;-3.68,-1.34,;-5.02,-.57,;-2.35,-.57,;-2.35,.97,;-3.68,1.74,;-5.02,.97,;-3.68,3.28,;-2.35,4.05,;-1.02,3.28,;-1.02,1.74,;.32,.97,;1.41,2.06,;1.09,-.36,;2.44,-1.02,;3.93,-1.42,;5.02,-.33,;4.62,1.16,;3.13,1.55,;2.04,.47,)|	InChI=1S/C22H18ClF2N3O/c23-20-16(25)9-17-14(10-22(11-26,28-17)12-5-2-1-3-6-12)19(20)18-13(21(27)29)7-4-8-15(18)24/h1-9,28H,10-11,26H2,(H2,27,29)	IWEVAJOUKPMFDX-UHFFFAOYSA-N	695413	US12083101, Example 134	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 74.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695413	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695413&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444195	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@](CNC3CCCCC3)(Oc2ccc1Cl)c1ccccc1 |r,wU:17.35,(1.91,4.96,;1.14,3.62,;1.91,2.29,;-.4,3.62,;-.4,5.16,;-1.73,5.93,;-3.06,5.16,;-4.4,5.93,;-5.73,5.16,;-7.06,5.93,;-5.73,3.62,;-3.06,3.62,;-4.4,2.85,;-1.73,2.85,;-1.73,1.31,;-.4,.54,;1.07,1.02,;1.97,-.23,;3.06,-1.31,;3.06,-2.85,;4.4,-3.62,;4.4,-5.16,;5.73,-5.93,;7.06,-5.16,;7.06,-3.62,;5.73,-2.85,;1.07,-1.47,;-.4,-1,;-1.73,-1.77,;-3.06,-1,;-3.06,.54,;-4.4,1.31,;3.31,.54,;4.64,-.23,;5.98,.54,;5.98,2.08,;4.64,2.85,;3.31,2.08,)|	InChI=1S/C29H28ClF3N2O3/c30-21-12-14-22-20(24(21)25-19(27(34)36)11-13-23(26(25)31)37-28(32)33)15-29(38-22,17-7-3-1-4-8-17)16-35-18-9-5-2-6-10-18/h1,3-4,7-8,11-14,18,28,35H,2,5-6,9-10,15-16H2,(H2,34,36)	COTWYXKEDPQCDT-UHFFFAOYSA-N	695414	US12083101, Example 135	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695414	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695414&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444196	CO[C@H]1CC[C@@H](CC1)NC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1O)-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:10.39,5.8,wD:20.23,2.1,(7.79,2.73,;6.3,2.33,;5.21,3.42,;5.61,4.91,;4.52,6,;3.03,5.6,;2.63,4.11,;3.72,3.02,;1.94,6.69,;2.34,8.18,;1.25,9.27,;.35,8.02,;-1.12,8.5,;-2.45,7.73,;-3.78,8.5,;-5.12,7.73,;-3.78,10.04,;-5.12,10.81,;-2.45,10.81,;-1.12,10.04,;.35,10.51,;1.68,11.28,;-2.45,12.35,;-3.78,13.12,;-5.12,12.35,;-3.78,14.66,;-5.12,15.43,;-6.45,14.66,;-7.79,15.43,;-6.45,13.12,;-2.45,15.43,;-1.12,14.66,;-1.12,13.12,;.22,12.35,;1.55,13.12,;-.55,11.01,;2.79,9.27,;3.56,7.93,;5.1,7.93,;5.87,9.27,;5.1,10.6,;3.56,10.6,)|	InChI=1S/C30H29ClF4N2O5/c1-40-17-9-7-16(8-10-17)37-14-30(15-5-3-2-4-6-15)27(38)23-21(42-30)13-19(32)25(31)24(23)22-18(28(36)39)11-12-20(26(22)33)41-29(34)35/h2-6,11-13,16-17,27,29,37-38H,7-10,14H2,1H3,(H2,36,39)	GJGXVZIMHDAHSN-UHFFFAOYSA-N	695415	US12083101, Example 136a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695415	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695415&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444197	CO[C@@H]1CC[C@@H](CC1)NC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1O)-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1	InChI=1S/C30H29ClF4N2O5/c1-40-17-9-7-16(8-10-17)37-14-30(15-5-3-2-4-6-15)27(38)23-21(42-30)13-19(32)25(31)24(23)22-18(28(36)39)11-12-20(26(22)33)41-29(34)35/h2-6,11-13,16-17,27,29,37-38H,7-10,14H2,1H3,(H2,36,39)	GJGXVZIMHDAHSN-UHFFFAOYSA-N	695416	US12083101, Example 136b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695416	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695416&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444198	COC(=O)[C@@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(F)ccc1C(N)=O)c1ccccc1 |r,wU:12.36,7.10,4.3,(6.99,-15.32,;5.9,-14.23,;4.41,-14.63,;4.01,-16.12,;3.32,-13.54,;3.72,-12.05,;2.63,-10.96,;1.15,-11.36,;.75,-12.85,;1.84,-13.94,;.06,-10.27,;.45,-8.79,;-.63,-7.7,;-1.54,-6.45,;-3,-6.93,;-3,-8.47,;-1.54,-8.94,;-4.34,-9.24,;-5.67,-8.47,;-5.67,-6.93,;-7.01,-6.16,;-4.34,-6.16,;-4.34,-4.62,;-5.67,-3.85,;-7.01,-4.62,;-5.67,-2.31,;-7.01,-1.54,;-4.34,-1.54,;-3,-2.31,;-3,-3.85,;-1.67,-4.62,;-.34,-3.85,;-2.44,-5.95,;.91,-7.7,;1.68,-9.03,;3.22,-9.03,;3.99,-7.7,;3.22,-6.36,;1.68,-6.36,)|	InChI=1S/C30H29ClF2N2O4/c1-38-29(37)17-7-9-19(10-8-17)35-16-30(18-5-3-2-4-6-18)15-21-24(39-30)14-12-22(31)25(21)26-20(28(34)36)11-13-23(32)27(26)33/h2-6,11-14,17,19,35H,7-10,15-16H2,1H3,(H2,34,36)	HIVGMNQNDIAWAQ-UHFFFAOYSA-N	695417	US12083101, Example 137a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695417	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695417&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444199	COC(=O)[C@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)c(F)ccc1C(N)=O)c1ccccc1	InChI=1S/C30H29ClF2N2O4/c1-38-29(37)17-7-9-19(10-8-17)35-16-30(18-5-3-2-4-6-18)15-21-24(39-30)14-12-22(31)25(21)26-20(28(34)36)11-13-23(32)27(26)33/h2-6,11-14,17,19,35H,7-10,15-16H2,1H3,(H2,34,36)	HIVGMNQNDIAWAQ-UHFFFAOYSA-N	695418	US12083101, Example 137b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695418	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695418&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444200	NC(=O)[C@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:11.34,6.9,wD:3.2,(6.44,-14.23,;4.96,-14.63,;4.56,-16.12,;3.87,-13.54,;4.27,-12.05,;3.18,-10.96,;1.69,-11.36,;1.29,-12.85,;2.38,-13.94,;.6,-10.27,;1,-8.79,;-.09,-7.7,;-.99,-6.45,;-2.46,-6.93,;-2.46,-8.47,;-.99,-8.94,;-3.79,-9.24,;-5.13,-8.47,;-5.13,-6.93,;-6.46,-6.16,;-3.79,-6.16,;-3.79,-4.62,;-5.13,-3.85,;-6.46,-4.62,;-5.13,-2.31,;-3.79,-1.54,;-2.46,-2.31,;-2.46,-3.85,;-1.13,-4.62,;.21,-3.85,;-1.9,-5.95,;1.45,-7.7,;2.22,-9.03,;3.76,-9.03,;4.53,-7.7,;3.76,-6.36,;2.22,-6.36,)|	InChI=1S/C29H29ClFN3O3/c30-22-13-14-24-21(25(22)26-20(28(33)36)7-4-8-23(26)31)15-29(37-24,18-5-2-1-3-6-18)16-34-19-11-9-17(10-12-19)27(32)35/h1-8,13-14,17,19,34H,9-12,15-16H2,(H2,32,35)(H2,33,36)	CLBKZLURERSYPE-UHFFFAOYSA-N	695419	US12083101, Example 138a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 18.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695419	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695419&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444201	NC(=O)[C@@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:11.34,6.9,3.2,(6.44,-14.23,;4.96,-14.63,;4.56,-16.12,;3.87,-13.54,;4.27,-12.05,;3.18,-10.96,;1.69,-11.36,;1.29,-12.85,;2.38,-13.94,;.6,-10.27,;1,-8.79,;-.09,-7.7,;-.99,-6.45,;-2.46,-6.93,;-2.46,-8.47,;-.99,-8.94,;-3.79,-9.24,;-5.13,-8.47,;-5.13,-6.93,;-6.46,-6.16,;-3.79,-6.16,;-3.79,-4.62,;-5.13,-3.85,;-6.46,-4.62,;-5.13,-2.31,;-3.79,-1.54,;-2.46,-2.31,;-2.46,-3.85,;-1.13,-4.62,;.21,-3.85,;-1.9,-5.95,;1.45,-7.7,;2.22,-9.03,;3.76,-9.03,;4.53,-7.7,;3.76,-6.36,;2.22,-6.36,)|	InChI=1S/C29H29ClFN3O3/c30-22-13-14-24-21(25(22)26-20(28(33)36)7-4-8-23(26)31)15-29(37-24,18-5-2-1-3-6-18)16-34-19-11-9-17(10-12-19)27(32)35/h1-8,13-14,17,19,34H,9-12,15-16H2,(H2,32,35)(H2,33,36)	CLBKZLURERSYPE-UHFFFAOYSA-N	695420	US12083101, Example 138b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 18.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695420	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695420&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444202	CNC(=O)[C@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:12.35,7.10,wD:4.3,(6.99,-15.32,;5.9,-14.23,;4.41,-14.63,;4.01,-16.12,;3.32,-13.54,;3.72,-12.05,;2.63,-10.96,;1.15,-11.36,;.75,-12.85,;1.84,-13.94,;.06,-10.27,;.45,-8.79,;-.63,-7.7,;-1.54,-6.45,;-3,-6.93,;-3,-8.47,;-1.54,-8.94,;-4.34,-9.24,;-5.67,-8.47,;-5.67,-6.93,;-7.01,-6.16,;-4.34,-6.16,;-4.34,-4.62,;-5.67,-3.85,;-7.01,-4.62,;-5.67,-2.31,;-4.34,-1.54,;-3,-2.31,;-3,-3.85,;-1.67,-4.62,;-.34,-3.85,;-2.44,-5.95,;.91,-7.7,;1.68,-9.03,;3.22,-9.03,;3.99,-7.7,;3.22,-6.36,;1.6			695421	US12083101, Example 139a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 21.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695421	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695421&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444203	CNC(=O)[C@@H]1CC[C@@H](CC1)NC[C@]1(Cc2c(O1)ccc(Cl)c2-c1c(F)cccc1C(N)=O)c1ccccc1 |r,wU:12.35,7.10,4.3,(6.99,-15.32,;5.9,-14.23,;4.41,-14.63,;4.01,-16.12,;3.32,-13.54,;3.72,-12.05,;2.63,-10.96,;1.15,-11.36,;.75,-12.85,;1.84,-13.94,;.06,-10.27,;.45,-8.79,;-.63,-7.7,;-1.54,-6.45,;-3,-6.93,;-3,-8.47,;-1.54,-8.94,;-4.34,-9.24,;-5.67,-8.47,;-5.67,-6.93,;-7.01,-6.16,;-4.34,-6.16,;-4.34,-4.62,;-5.67,-3.85,;-7.01,-4.62,;-5.67,-2.31,;-4.34,-1.54,;-3,-2.31,;-3,-3.85,;-1.67,-4.62,;-.34,-3			695422	US12083101, Example 139b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695422	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695422&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444204	NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](CNC3CC(C3)C(F)F)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:17.37,(2.54,15.06,;1.2,14.29,;.43,12.95,;-.13,15.06,;-.13,16.6,;-1.47,17.37,;-2.8,16.6,;-4.13,17.37,;-5.47,16.6,;-6.8,17.37,;-8.13,16.6,;-2.8,15.06,;-4.13,14.29,;-1.47,14.29,;-1.47,12.75,;-.13,11.98,;1.33,12.45,;2.24,11.21,;3.33,10.12,;2.93,8.63,;4.02,7.54,;4.02,6,;5.56,6,;5.56,7.54,;6.65,4.91,;6.25,3.42,;8.13,5.31,;1.33,9.96,;-.13,10.44,;-1.47,9.67,;-2.8,10.44,;-4.13,9.67,;-2.8,11.98,;-4.13,12.75,			695423	US12083101, Example 140a	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695423	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695423&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444205	NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@@](CNC3CC(C3)C(F)F)(Oc2cc(F)c1Cl)c1ccccc1 |r,wD:17.37,(2.54,15.06,;1.2,14.29,;.43,12.95,;-.13,15.06,;-.13,16.6,;-1.47,17.37,;-2.8,16.6,;-4.13,17.37,;-5.47,16.6,;-6.8,17.37,;-8.13,16.6,;-2.8,15.06,;-4.13,14.29,;-1.47,14.29,;-1.47,12.75,;-.13,11.98,;1.33,12.45,;2.24,11.21,;3.33,10.12,;2.93,8.63,;4.02,7.54,;4.02,6,;5.56,6,;5.56,7.54,;6.65,4.91,;6.25,3.42,;8.13,5.31,;1.33,9.96,;-.13,10.44,;-1.47,9.67,;-2.8,10.44,;-4.13,9.67,;-2.8,11.98,;-4.13,12.75,;3.78,11.21,;4.55,9.87,;6.09,9.87,;6.86,11.21,;6.09,12.54,;4.55,12.54,)|	InChI=1S/C29H27ClF4N2O4/c30-25-20(31)12-22-19(23(25)24-18(28(35)38)6-7-21(26(24)32)39-9-8-37)13-29(40-22,16-4-2-1-3-5-16)14-36-17-10-15(11-17)27(33)34/h1-7,12,15,17,27,36-37H,8-11,13-14H2,(H2,35,38)	XZPPCXAMFOMCIA-UHFFFAOYSA-N	695424	US12083101, Example 140b	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 6.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695424	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695424&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444206	CNC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wU:18.30,(4.51,.74,;3.17,1.51,;1.84,.74,;1.07,-.59,;.51,1.51,;.51,3.05,;-.83,3.82,;-2.16,3.05,;-			695425	US12083101, Example 141	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695425	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695425&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444207	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OC(F)F)ccc1C(N)=O)c1ccccc1 |r,wU:3.30,(4.23,-3.98,;2.9,-3.21,;3.3,-1.73,;2.21,-.64,;1.3,.61,;-.16,.13,;-.16,-1.41,;1.3,-1.88,;-1.49,-2.18,;-2.83,-1.41,;-4.16,-2.18,;-2.83,.13,;-4.16,.9,;-1.49,.9,;-1.49,2.44,;-2.83,3.21,;-4.16,2.44,;-2.83,4.75,;-4.16,5.52,;-5.5,4.75,;-6.83,5.52,;-5.			695426	US12083101, Example 142	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695426	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695426&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444208	CNC[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O)c1ccccc1 |r,wU:3.30,(4.9,-4.53,;3.57,-3.76,;3.96,-2.27,;2.88,-1.18,;1.97,.06,;.51,-.41,;.51,-1.95,;1.97,-2.43,;-.83,-2.72,;-2.16,-1.95,;-3.49,-2.72,;-2.16,-.41,;-3.49,.36,;-.83,.36,;-.83			695427	US12083101, Example 143	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695427	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695427&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444209	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OC)ccc1C(N)=O)c1ccccc1 |r,wD:3.2,13.15,(5.18,-4.62,;3.85,-3.85,;3.85,-2.31,;2.51,-1.54,;1.61,-2.78,;.15,-2.31,;-1.18,-3.08,;-2.52,-2.31,;-3.85,-3.08,;-2.52,-.77,;-3.86,-0,;-1.18,0,;.15,-.77,;1.61,-.3,;2.01,1.19,;-1.18,1.54,;.15,2.31,;1.49,1.54,;.15,3.85,;1.49,4.62,;2.82,3.85,;-1.18,4.62,;-2.52,3.85,;-2.52,2.31,;-3.98,1.83,;-5.13,2.86,;-4.3,.33,;3.85,-.77,;5.18,-1.54,;6.52,-.78,;6.52,.76,;5.19,1.54,;3.85,.77,)|	InChI=1S/C25H23ClF2N2O3/c1-13-19-18(33-25(13,12-30-2)14-7-5-4-6-8-14)11-16(27)22(26)21(19)20-15(24(29)31)9-10-17(32-3)23(20)28/h4-11,13,30H,12H2,1-3H3,(H2,29,31)	SZTDDOZZDHCJIE-UHFFFAOYSA-N	50626284	US12083101, Example 144::CHEMBL5437387	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50626284	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50626284&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search			156855384	505044256							3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444210	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1C)-c1c(F)c(OCCO)ncc1C(=O)NC)c1ccccc1 |r,wD:3.2,13.15,(5.61,-4.92,;4.27,-4.15,;4.27,-2.61,;3.19,-1.52,;2.28,-2.76,;.82,-2.29,;-.52,-3.06,;-1.85,-2.29,;-3.19,-3.06,;-1.85,-.75,;-3.19,.02,;-.52,.02,;.82,-.75,;2.28,-.27,;2.28,1.27,;-.52,1.56,;-1.85,2.33,;-3.19,1.56,;-1.85,3.87,;-3.19,4.64,;-4.52,3.87,;-5.85,4.64,;-7.19,3.87,;-.52,4.64,;.82,3.87,;.82,2.33,;2.15,2.34,;3			695429	US12083101, Example 145	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695429	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695429&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444211	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1COC)-c1c(F)c(OC)ccc1C(N)=O)c1ccccc1 |r,wD:3.2,13.15,(3.48,-4.91,;2.39,-3.82,;2.79,-2.34,;1.7,-1.25,;.79,-2.49,;-.67,-2.02,;-2.01,-2.79,;-3.34,-2.02,;-4.67,-2.79,;-3.34,-.48,;-4.67,.29,;-2.01,.29,;-.67,-.48,;.79,-0,;1.88,1.09,;3.42,1.09,;4.19,2.42,;-2.01,1.83,;-3.34,2.6,;-4.67,1.83,;-3.34,4.14,;-4.67,4.91,;-6.01,4.14,;-2.01,4.91,;-.67,4.14,;-.67,2.6,;.66,2.61,;2.08			695430	US12083101, Example 146	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695430	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695430&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444212	CNC[C@@]1(Oc2cc(F)c(Cl)c(c2[C@@H]1CO)-c1c(F)c(OC)ccc1C(N)=O)c1ccccc1 |r,wU:3.30,wD:13.15,(1.65,-5.85,;.88,-4.52,;1.65,-3.18,;.88,-1.85,;-.03,-3.1,;-1.49,-2.62,;-2.83,-3.39,;-4.16,-2.62,;-5.5,-3.39,;-4.16,-1.08,;-5.5,-.31,;-2.83,-.31,;-1.49,-1.08,;-.03,-.6,;.45,.86,;1.99,.86,;-2.83,1.23,;-4.16,2,;-5.5,1.23,;-4.16,3.54,;-5.5,4.31,;-5.5,5.85,;-2.83,4.31,;-1.49,3.54,;-1.49,2,;-.16,1.23,;.24,2.72,;-.93			695431	US12083101, Example 147	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695431	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695431&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444213	C[C@H]1c2c(O[C@]1(CN[C@H]1CC[C@](C)(O)CC1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCC(C)(C)O)ccc1C(N)=O |r,wU:5.17,8.8,11.12,wD:11.13,1.0,(2.62,2.15,;1.53,1.06,;.07,.59,;.07,-.95,;1.53,-1.43,;2.44,-.18,;3.53,-1.27,;3.13,-2.76,;4.22,-3.85,;5.7,-3.45,;6.79,-4.54,;6.39,-6.03,;7.93,-6.03,;6.79,-7.52,;4.91,-6.43,;3.82,-5.34,;3.98,-.18,;4.75,-1.52,;6.29,-1.52,;7.06,-.18,;6.29,1.15,;4.75,1.15,;-1.27,-1.72,;-2.6,-.95,;-3.93,-1.72,;-2.6,.59,;-3.93,1.36,;-1.27,1.36,;-1.27,2.9,;-2.6,3.67,;-3.93,2.9,;-2.6,5.21,;-3.93,5.98,;-5.27,5.21,;-6.6,5.98,;-7.93,6.75,;-7.93,5.21,;-6.6,7.52,;-1.27,5.98,;.07,5.21,;.07,3.67,;1.4,2.9,;2.73,3.67,;.63,1.56,)|	InChI=1S/C34H39ClF2N2O5/c1-19-26-25(44-34(19,20-8-6-5-7-9-20)17-39-21-12-14-33(4,42)15-13-21)16-23(36)29(35)28(26)27-22(31(38)40)10-11-24(30(27)37)43-18-32(2,3)41/h5-11,16,19,21,39,41-42H,12-15,17-18H2,1-4H3,(H2,38,40)	IYDRWSXPAUEKRD-UHFFFAOYSA-N	695432	US12083101, Example 148	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695432&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444214	CNC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)(C1CCN1)c1ccccc1 |r,wD:18.33,(-1.37,11.04,;-1.37,9.5,;-.04,8.73,;-.94,7.48,;1.29,9.5,;1.29,11.04,;2.63,11.81,;3.96,11.04,;5.3,11.81,;5.3,13.35,;6.63,14.12,;6.63,15.66,;3.96,9.5,;5.3,8.73,;2.63,8.73,;2.63,7.19,;1.29,6.42,;-.17,6.89,;-1.07,5.65,;-.17,4.4,;1.29,4.88,;2.63,4.11,;3.96,4.88,;5.3,4.11,;3.96,6.42,;5.3,7.19,;-2.42,6.4,;-3.9,5.99,;-4.31,7.47,;-2.83,7.89,;-2.12,4.51,;-1.66,3.04,;-2.7,1.91,;-4.2,2.25,;-4.66,3.72,;-3.62,4.85,)|	InChI=1S/C27H25ClF2N2O4/c1-31-26(34)16-7-8-19(35-12-11-33)25(30)23(16)22-17-14-27(21-9-10-32-21,15-5-3-2-4-6-15)36-20(17)13-18(29)24(22)28/h2-8,13,21,32-33H,9-12,14H2,1H3,(H,31,34)	KACQRXNCQXVKOO-UHFFFAOYSA-N	695433	US12083101, Example 149	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695433	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695433&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444215	CNC(=O)c1ccc(OC[C@H](C)O)c(F)c1-c1c2[C@H](C)[C@@](Oc2cc(F)c1Cl)(C1CCN1)c1ccccc1 |r,wU:20.35,wD:10.11,18.19,(4.25,2.65,;3.48,1.31,;2.15,.54,;1.06,-.54,;.82,1.31,;.82,2.85,;-.52,3.62,;-1.85,2.85,;-3.19,3.62,;-4.52,2.85,;-5.85,3.62,;-7.19,2.85			695434	US12083101, Example 150	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695434	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695434&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444216	NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:17.33,wD:25.32,(3.29,3.76,;2.52,2.42,;2.92,.94,;.98,2.42,;.98,3.96,;-.35,4.73,;-1.68,3.96,;-3.02,4.73,;-4.35,3.96,;-5.68,4.73,;-7.02,3.96,;-1.68,2.42,;-3.02,1.65,;			695435	US12083101, Example 151	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695435	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695435&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444217	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:18.34,wD:1.1,26.33,(-6.52,4.42,;-5.19,5.19,;-5.19,6.73,;-3.85,4.42,;-3.85,2.88,;-2.52,2.11,;-1.18,2.88,;.15,2.11,;.15,.57,;1.69,.57,;2.46,1.91,;2.46,-.76,;-1.18,-.2,;-2.52,.57,;-3.85,-.2,;-1.18,-1.74,;.15,-2.51,;1.61,-2.03,;2.52,-3.28,;1.61,-4.52,;.15,-4.05,;-1.18,-4.82,;-2.52,-4.05,;-3.85,-4.82,;-2.52,-2.51,;-3.85,-1.74,;3.61,-4.36,;5.15,-4.36,;5.62,-5.83,;4.38,-6.73,;3.13,-5.83,;3.85,-2.51,;			695436	US12083101, Example 152	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695436	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695436&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444218	CNC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:26.33,wD:18.34,(5.33,-4.62,;5.33,-3.08,;4,-2.31,;4,-.77,;2.67,-3.08,;2.67,-4.62,;1.33,-5.39,;,-4.62,;-1.33,-5.39,;-1.33,-6.93,;-2.67,-7.7,;-2.67,-9.24,;,-3.08,;-1.33,-2.31,;1.33,-2.31,;1.33,-.77,;;-1.46,-.48,;-2.37,.77,;-1.46,2.02,;,1.54,;1.33,2.31,;2.67,1.54,;4,2.31,;2.67,,;4.2,.16,;-3.51,-.26,;-5.02,.06,;-5.79,-1.27,;-4.76,-2.42,;-3.35,-1.79,;-3.51,1.8,;-4.98,1.32,;-6.12,2.35,;-5.8,3.86,;-4.34,4.34			695437	US12083101, Example 153::2-((2S,4S)-5-Chloro-6-fluoro-2-phenyl-2-((S)-pyrrolidin-2-yl)-2,3-dihydrobenzofuran-4-yl)-3-fluoro-4-(2-hydroxyethoxy)-N-methylbenzamide	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		<1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695437	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695437&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444219	CNC(=O)c1ccc(OC[C@H](C)O)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:19.35,wD:27.34,10.11,(3.48,3.27,;3.48,1.73,;2.15,.96,;1.38,-.37,;.82,1.73,;.82,3.27,;-.52,4.04,;-1.85,3.27,;-3.19,4.04,;-4.52,3.27,;-5.85,4.04,;-7.19,3.27,;-5.85,5.58,;-1.85,1.73,;-3.19,.96,;-.52,.96,;-.52,-.58,;.82,-1.35,;2.28,-.87,;3.19,-2.12,;2.28,-3.37,;.82,-2.89,;-.52,-3.66,;-1.85,-2.89,;-3.19,-3.66,;-1.85,-1.35,;-3.19,-.58,;4.27,-3.21,;5.81,-3.21,;6.29,-4.67,;5.04,-5.58,;3.8,-4.67,;4.52,-1.35,;5.85,-2.12,;7.19,-1.35,;7.19,.19,;5.85,.96,;4.52,.19,)|	InChI=1S/C29H29ClF2N2O4/c1-16(35)15-37-21-11-10-18(28(36)33-2)25(27(21)32)24-19-14-29(23-9-6-12-34-23,17-7-4-3-5-8-17)38-22(19)13-20(31)26(24)30/h3-5,7-8,10-11,13,16,23,34-35H,6,9,12,14-15H2,1-2H3,(H,33,36)	NHLFHLRMJGOIIT-UHFFFAOYSA-N	695438	US12083101, Example 154	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 8.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695438	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695438&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444220	CNC(=O)c1cnc(OCCO)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:18.34,wD:26.33,(4.82,1.73,;3.48,2.5,;2.15,1.73,;2.92,.4,;.82,2.5,;.82,4.04,;-.52,4.81,;-1.85,4.04,;-3.19,4.81,;-4.52,4.04,;-5.85,4.81,;-7.19,4.04,;-1.85,2.5,;-3.19,1.73,;-.52,1.73,;-.52,.19,;.82,-.58,;2.28,-.1,;3.19,-1.35,;2.28,-2.6,;.82,-2.12,;-.52,-2.89,;-1.85,-2.12,;-3.19,-2.89,;-1.85,-.58,;-3.19,.19,;4.27,-2.44,;5.81,-2.44,;6.29,-3.9,;5.04,-4.81,;3.8,-3.9,;4.52,-.58,;5.85,-1.35,;7.19,-.58,;7.19,.96,;5.85,1.73,;4.52,.96,)|	InChI=1S/C27H26ClF2N3O4/c1-31-25(35)17-14-33-26(36-11-10-34)24(30)22(17)21-16-13-27(20-8-5-9-32-20,15-6-3-2-4-7-15)37-19(16)12-18(29)23(21)28/h2-4,6-7,12,14,20,32,34H,5,8-11,13H2,1H3,(H,31,35)	HUVOYQMXUNTUAI-UHFFFAOYSA-N	695439	US12083101, Example 155	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 9.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695439&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444221	CNC(=O)c1cnc(OCC(O)=O)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:19.35,wD:27.34,(4.73,8.33,;3.24,8.73,;2.15,7.64,;2.92,6.31,;.82,8.41,;.82,9.95,;-.52,10.72,;-1.85,9.95,;-3.19,10.72,;-4.52,9.95,;-5.85,10.72,;-7.19,9.95,;-5.85,12.26,;-1.85,8.41,;-3.19,7.64,;-.52,7.64,;-.52,6.1,;.82,5.33,;2.28,5.81,;3.19,4.56,;2.28,3.31,;.82,3.79,;-.52,3.02,;-1.85,3.79,;-3.19,3.02,;-1.85,5.33,;-3.19,6.1,;4.27,3.47,;5.74,3.95,;6.64,2.7,;5.74,1.46,;4.27,1.93,;4.52,5.33,;5.85,4.56,;7.19,5.33,;7.19,6.87,;5.85,7.64,;4.52,6.87,)|	InChI=1S/C27H24ClF2N3O5/c1-31-25(36)16-12-33-26(37-13-20(34)35)24(30)22(16)21-15-11-27(19-8-5-9-32-19,14-6-3-2-4-7-14)38-18(15)10-17(29)23(21)28/h2-4,6-7,10,12,19,32H,5,8-9,11,13H2,1H3,(H,31,36)(H,34,35)	JFVAEAGYOFWBBB-UHFFFAOYSA-N	695440	US12083101, Example 156	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 11.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695440	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695440&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444222	CNC(=O)c1cnc(O)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:15.31,wD:23.30,(4.73,8.33,;3.24,8.73,;2.15,7.64,;2.92,6.31,;.82,8.41,;.82,9.95,;-.52,10.72,;-1.85,9.95,;-3.19,10.72,;-1.85,8.41,;-3.19,7.64,;-.52,7.64,;-.52,6.1,;.82,5.33,;2.28,5.81,;3.19,4.56,;2.28,3.31,;.82,3.79,;-.52,3.02,;-1.85,3.79,;-3.19,3.02,;-1.85,5.33,;-3.19,6.1,;4.27,3.47,;5.74,3.95,;6.64,2.7,;5.74,1.46,;4.27,1.93,;4.52,5.33,;5.85,4.56,;7.19,5.33,;7.19,6.87,;5.85,7.64,;4.52,6.87,)|	InChI=1S/C25H22ClF2N3O3/c1-29-23(32)15-12-31-24(33)22(28)20(15)19-14-11-25(18-8-5-9-30-18,13-6-3-2-4-7-13)34-17(14)10-16(27)21(19)26/h2-4,6-7,10,12,18,30H,5,8-9,11H2,1H3,(H,29,32)(H,31,33)	OIBPBNLQVVCDQD-UHFFFAOYSA-N	695441	US12083101, Example 157	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 75.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695441	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695441&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444223	NC(=O)c1ccc(OC(F)F)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)(C1CC(O)CN1)c1ccccc1 |r,wU:17.34,(2.57,2.05,;1.08,1.65,;.31,.32,;-.25,2.42,;-.25,3.96,;-1.58,4.73,;-2.92,3.96,;-4.25,4.73,;-5.58,3.96,;-6.92,4.73,;-5.58,2.42,;-2.92,2.42,;-4.25,1.65,;-1.58,1.65,;-1.58,.11,;-.25,-.66,;1.22,-.18,;2.12,-1.43,;1.22,-2.67,;-.25,-2.2,;-1.58,-2.97,;-2.92,-2.2,;-4.25,-2.97,;-2.92,-.66,;-4.25,.11,;3.21,-2.51,;4.73,-2.27,;5.43,-3.65,;6.92,-4.04,;4.34,-4.73,;2.97,-4.04,;3.45,-.66,;4.79,-1.43,;6.12,-.66,;6.12,.88,;4.79,1.65,;3.45,.88,)|	InChI=1S/C26H21ClF4N2O4/c27-22-16(28)9-18-15(20(22)21-14(24(32)35)6-7-17(23(21)29)36-25(30)31)10-26(37-18,12-4-2-1-3-5-12)19-8-13(34)11-33-19/h1-7,9,13,19,25,33-34H,8,10-11H2,(H2,32,35)	AAIYLALYZUHGES-UHFFFAOYSA-N	695442	US12083101, Example 158	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695442	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695442&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444224	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2C[C@@](Oc2cc(F)c1Cl)(C1CC(C)(O)CN1)c1ccccc1 |r,wU:18.36,wD:1.1,(-7.58,3.19,;-6.25,3.96,;-6.25,5.5,;-4.92,3.19,;-3.58,3.96,;-2.25,3.19,;-.92,3.96,;.42,3.19,;.42,1.65,;1.75,.88,;3.24,1.28,;.98,-.45,;-.92,.88,;-2.25,1.65,;-3.58,.88,;-.92,-.66,;.42,-1.43,;1.88,-.95,;2.79,-2.2,;1.88,-3.44,;.42,-2.97,;-.92,-3.74,;-2.25,-2.97,;-3.58,-3.74,;-2.25,-1.43,;-3.58,-.66,;3.88,-3.28,;5.4,-3.04,;6.1,-4.42,;6.87,-3.08,;7.58,-4.81,;5.01,-5.5,;3.64,-4.81,;4.12,-1.43,;5.45,-2.2,;6.79,-1.43,;6.79,.11,;5.45,.88,;4.12,.11,)|	InChI=1S/C29H29ClF2N2O5/c1-15(35)13-38-20-9-8-17(27(33)36)24(26(20)32)23-18-11-29(16-6-4-3-5-7-16,22-12-28(2,37)14-34-22)39-21(18)10-19(31)25(23)30/h3-10,15,22,34-35,37H,11-14H2,1-2H3,(H2,33,36)	FDTUKKNRYFGTGU-UHFFFAOYSA-N	695443	US12083101, Example 159	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 122							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695443	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695443&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444225	F[C@H]1CN[C@@H](C1)[C@]1(Cc2c(O1)cc(F)c(Cl)c2-c1ccccc1)c1ccccc1 |r|	InChI=1S/C24H20ClF2NO/c25-23-19(27)12-20-18(22(23)15-7-3-1-4-8-15)13-24(29-20,16-9-5-2-6-10-16)21-11-17(26)14-28-21/h1-10,12,17,21,28H,11,13-14H2	YEJPCDWOXMUVMF-UHFFFAOYSA-N	695444	US12083101, Example 160	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4400							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695444	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695444&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444226	CNC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCCN1)c1ccccc1 |r,wU:18.35,wD:26.34,(4.82,1.83,;3.48,2.6,;2.15,1.83,;2.92,.5,;.82,2.6,;.82,4.14,;-.52,4.91,;-1.85,4.14,;-3.19,4.91,;-4.52,4.14,;-5.85,4.91,;-7.19,4.14,;-1.85,2.6,;-3.19,1.83,;-.52,1.83,;-.52,.29,;.82,-.48,;2.28,-0,;3.19,-1.25,;2.28,-2.49,;.82,-2.02,;-.52,-2.79,;-1.85,-2.02,;-3.19,-2.79,;-1.85,-.48,;-3.19,.29,;4.27,-2.34,;5.76,-1.94,;6.85,-3.03,;6.45,-4.51,;4.96,-4.91,;3.88,-3.82,;4.52,-.48,;5.85,-1.25,;7.19,-.48,;7.19,1.06,;5.85,1.83,;4.52,1.06,)|	InChI=1S/C29H29ClF2N2O4/c1-33-28(36)18-10-11-21(37-14-13-35)27(32)25(18)24-19-16-29(17-7-3-2-4-8-17,23-9-5-6-12-34-23)38-22(19)15-20(31)26(24)30/h2-4,7-8,10-11,15,23,34-35H,5-6,9,12-14,16H2,1H3,(H,33,36)	PUBJTWTVDULJJM-UHFFFAOYSA-N	695445	US12083101, Example 161	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 29.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695445	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695445&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444227	Fc1cc2O[C@](Cc2c(c1Cl)-c1ccccc1)(C1COCCN1)c1ccccc1 |r|	InChI=1S/C24H21ClFNO2/c25-23-19(26)13-20-18(22(23)16-7-3-1-4-8-16)14-24(29-20,17-9-5-2-6-10-17)21-15-28-12-11-27-21/h1-10,13,21,27H,11-12,14-15H2	XIMLGINFHCEHSH-UHFFFAOYSA-N	695446	US12083101, Example 162	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1520							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695446	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695446&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444228	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@@](Oc2cc(F)c1Cl)(C1COCCN1)c1ccccc1 |r,wU:15.32,(-5.85,4.31,;-4.52,5.08,;-3.19,4.31,;-1.85,5.08,;-.52,4.31,;-.52,2.77,;.82,2,;2.15,2.77,;1.59,.67,;-1.85,2,;-3.19,2.77,;-4.52,2,;-1.85,.46,;-.52,-.31,;.95,.17,;1.85,-1.08,;.95,-2.33,;-.52,-1.85,;-1.85,-2.62,;-3.19,-1.85,;-4.52,-2.62,;-3.19,-.31,;-4.52,.46,;2.62,-2.41,;4.16,-2.41,;4.93,-3.75,;4.16,-5.08,;2.62,-5.08,;1.85,-3.75,;3.19,-.31,;4.52,-1.08,;5.85,-.31,;5.85,1.23,;4.52,2,;3.19,1.23,)|	InChI=1S/C26H23ClF2N2O4/c1-33-18-8-7-15(25(30)32)22(24(18)29)21-16-12-26(14-5-3-2-4-6-14,20-13-34-10-9-31-20)35-19(16)11-17(28)23(21)27/h2-8,11,20,31H,9-10,12-13H2,1H3,(H2,30,32)	WPGDPHZNBBHPMU-UHFFFAOYSA-N	695447	US12083101, Example 163	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 130							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695447	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695447&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444229	COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](O)[C@@](Oc2cc(F)c1Cl)(C1CCCN1)c1ccccc1 |r,wU:16.32,wD:14.15,(-6.16,4.12,;-4.83,4.89,;-3.49,4.12,;-2.16,4.89,;-.83,4.12,;-.83,2.58,;.51,1.81,;1.84,2.58,;-.26,.48,;-2.16,1.81,;-3.49,2.58,;-4.83,1.81,;-2.16,.47,;-.83,-.3,;.64,.18,;2.12,.58,;1.54,-1.07,;.64,-2.31,;-.83,-1.84,;-2.16,-2.61,;-3			695448	US12083101, Example 164	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695448	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695448&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444230	CO[C@H]1c2c(O[C@]1(C1CCCN1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OC)ccc1C(N)=O |r,wU:6.13,wD:2.1,(3.21,1.67,;2.12,.58,;.64,.18,;-.83,-.3,;-.83,-1.84,;.64,-2.31,;1.54,-1.07,;2.31,-2.4,;3.78,-2.88,;3.78,-4.42,;2.31,-4.89,;1.41,-3.65,;3.08,-1.07,;3.85,-2.4,;5.39,-2.4,;6.16,-1.07,;5.39,.27,;3.85,.27,;-2.16,-2.61,;-3.49,-1.84,;-4.8			695449	US12083101, Example 165	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 5.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695449	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695449&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444231	CO[C@H]1c2c(O[C@]1(C1CCCN1)c1ccccc1)cc(F)c(Cl)c2-c1c(F)c(OCCO)ccc1C(N)=O |r,wU:6.13,wD:2.1,(3.91,1.59,;3.51,.1,;1.97,.1,;.51,-.38,;.51,-1.92,;1.97,-2.39,;2.88,-1.15,;3.65,-2.48,;5.11,-2.96,;5.11,-4.5,;3.65,-4.97,;2.74,-3.73,;4.42,-1.15,;5.19,-2.48,;6.73,-2.48,;7.5,-1.15,;6.73,.19,;5.19,.19,;-.83,-2.69,;-2.16,-1.92,;-3.49,-2.69,;-2.16,-.38,;-3.49,.39,;-.83,.39,;-.83,1.89,;-2.16,2.66,;-3.49,1.89,;-2			695450	US12083101, Example 166	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 8.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695450	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695450&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444232	C[C@H](O)COc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@@](Oc2cc(F)c1Cl)(C1CCCN1)c1ccccc1 |r,wU:19.35,wD:17.18,1.1,(-7.19,3.41,;-5.85,4.18,;-5.85,5.72,;-4.52,3.41,;-3.19,4.18,;-1.85,3.41,;-.52,4.18,;.82,3.41,;.82,1.87,;2.36,1.87,;3.13,3.21,;3.13,.54,;-.52,1.1,;-1.85,1.87,;-3.19,1.1,;-.52,-.48,;.82,-1.25,;2.28,-.77,;2.28,.45,;3.1			695451	US12083101, Example 167	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 10.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695451	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695451&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444233	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@@](Oc2ccc1Cl)(C(C)N)c1ccccc1 |r,wU:15.27,(-5.85,3.6,;-4.52,4.37,;-3.19,3.6,;-1.85,4.37,;-.52,3.6,;-.52,2.06,;.82,1.29,;2.3,1.69,;.42,-.2,;-1.85,1.29,;-3.19,2.06,;-4.52,1.29,;-1.85,-.25,;-.52,-1.02,;.95,-.55,;1.85,-1.79,;.95,-3.04,;-.52,-2.56,;-1.85,-3.33,;-3.19,-2.56,;-3.19,-1.02,;-4.52,-.			695452	US12083101, Example 168	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 12.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695452	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695452&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444234	COCCOc1ccc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@@](Oc2cc(F)c1Cl)(C(C)N)c1ccccc1 |r,wU:19.32,wD:17.18,(-7.85,4.41,;-6.52,3.64,;-5.19,4.41,;-3.85,3.64,;-2.52,4.41,;-1.18,3.64,;.15,4.41,;1.48,3.64,;1.48,2.1,;2.82,1.33,;4.15,2.1,;2.05,,;.15,1.33,;-1.18,2.1,;-2.52,1.33,;.15,-.21,;1.48,-.98,;2.95,-.5,;4.28,.27,;3.85,-1.75,;2.95,-2.99,;1.48,-2.52,;.15,-3.29,;-1.18,-2.52,;-2.52,-3.29,;-1.18,-.98,;-2.52,-.21,;4.62			695453	US12083101, Example 169	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 7.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695453	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695453&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444235	NC(=O)c1ccc(OCCO)c(F)c1-c1c2C[C@@](Nc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:17.33,wD:25.32,(3.63,2.44,;2.3,1.67,;2.3,.13,;.96,2.44,;.96,3.98,;-.37,4.75,;-1.7,3.98,;-3.04,4.75,;-4.37,3.98,;-5.7,4.75,;-7.04,3.98,;-1.7,2.44,;-3.04,1.67,;-.37,1.67,;-.37,-.43,;.96,-1.2,;2.43,-.72,;3.33,-1.97,;2.43,-3.21,;.96,-2.74,;-.37,-3.51,;-1.7,-2.74,;-3.04,-3.51,;-1.7,-1.2,;-3.04,-.43,;4.67,-2.74,;6.13,-2.26,;7.04,-3.51,;6.13,-4.75,;4.67,-4.28,;4.42,-.88,;5.91,-1.28,;7,-.19,;6.6,1.3,;5.11,1.			695454	US12083101, Example 170	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 1.000							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695454	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695454&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444236	COc1ccc(C(N)=O)c(c1F)-c1c2C[C@@](Nc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:15.31,wD:23.30,(-5.7,3.98,;-4.37,4.75,;-3.04,3.98,;-1.7,4.75,;-.37,3.98,;-.37,2.44,;.96,1.67,;2.3,2.44,;.96,.13,;-1.7,1.67,;-3.04,2.44,;-4.37,1.67,;-1.7,-.43,;-.37,-1.2,;1.1,-.72,;2,-1.97,;1.1,-3.21,;-.37,-2.74,;-1.7,-3.51,;-3.04,-2.74,;-4.37,-3.51,;-3.04,-1.2,;-4.37,-.43,;3.33,-2.74,;4.8,-2.26,;5.7,-3.51,;4.8,-4.75,;3.33,-			695455	US12083101, Example 171	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 2.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695455	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695455&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444237	CNC(=O)c1ccc(OC[C@H](C)O)c(F)c1-c1c2C[C@@](Nc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:19.35,wD:27.34,10.11,(3.65,3.24,;3.65,1.7,;2.32,.93,;2.32,-.61,;.98,1.7,;.98,3.24,;-.35,4.01,;-1.68,3.24,;-3.02,4.01,;-4.35,3.24,;-5.68,4.01,;-7.02,3.24,;-5.68,5.55,;-1.68,1.7,;-3.02,.93,;-.35,.93,;-.35,-.9,;.98,-1.67,;2.45,-1.2,;3.35,-2.44,;2.45,-3.69,;.98,-3.21,;-.35,-3.98,;-1.68,-3.21,;-3.02,-3.98,;-1.68,-1.67,;-3.02,-.9,;4.44,-3.53,;5.91,-3.05,;6.81,-4.3,;5.91,-5.55,;4.44,-5.07,;4.44,-1.3			695456	US12083101, Example 172	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 15.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695456	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695456&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444238	CNC(=O)c1cnc(OCCO)c(F)c1-c1c2C[C@@](Nc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:18.34,wD:26.33,(3.65,4.02,;3.65,2.48,;2.32,1.71,;2.32,.17,;.98,2.48,;.98,4.02,;-.35,4.79,;-1.68,4.02,;-3.02,4.79,;-4.35,4.02,;-5.68,4.79,;-7.02,4.02,;-1.68,2.48,;-3.02,1.71,;-.35,1.71,;-.35,-.15,;.98,-.92,;2.45,-.44,;3.35,-1.69,;2.45,-2.94,;.98,-2.46,;-.35,-3.23,;-1.68,-2.46,;-3.02,-3.23,;-1.68,-.92,;-3.02,-.15,;4.44,-2.78,;5.91,-2.3,;6.81,-3.55,;5.91,-4.79,;4.44,-4.32,;4.44,-.6,;5.93,-1,;7.02,.09,;			695457	US12083101, Example 173	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 14.0							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695457	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695457&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444239	COc1ncc(C(N)=O)c(c1F)-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:15.31,wD:23.30,(-5.68,3.99,;-4.35,4.76,;-3.02,3.99,;-1.68,4.76,;-.35,3.99,;-.35,2.45,;.98,1.68,;2.32,2.45,;1.75,.35,;-1.68,1.68,;-3.02,2.45,;-4.35,1.68,;-1.68,.14,;-.35,-.63,;1.11,-.15,;2.02,-1.4,;1.11,-2.64,;-.35,-2.17,;-1.68,-2.94,;-3.02,-2.17,;-4.35,-2.94,;-3.02,-.63,;-4.35,.14,;3.11,-2.49,;4.64,-2.33,;5.26,-3.74,;4.12,-4.76,;2.78,-3.99,;3.11,-.31,;4.6,-.71,;5.68,.38,;5.29,1.87,;3.8,2.27,;2.71,1.18,)|	InChI=1S/C25H22ClF2N3O3/c1-33-24-22(28)20(15(12-31-24)23(29)32)19-14-11-25(18-8-5-9-30-18,13-6-3-2-4-7-13)34-17(14)10-16(27)21(19)26/h2-4,6-7,10,12,18,30H,5,8-9,11H2,1H3,(H2,29,32)	AMFKHGDRUVSWSL-UHFFFAOYSA-N	695458	US12083101, Example 174	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695458	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695458&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444240	CNC(=O)c1cnc(OC)c(F)c1-c1c2C[C@@](Oc2cc(F)c1Cl)([C@@H]1CCCN1)c1ccccc1 |r,wU:16.32,wD:24.31,(3.69,2.43,;2.15,2.43,;.82,1.66,;1.59,.33,;-.52,2.43,;-.52,3.97,;-1.85,4.74,;-3.19,3.97,;-4.52,4.74,;-5.85,3.97,;-3.19,2.43,;-4.52,1.66,;-1.85,1.66,;-1.85,.12,;-.52,-.65,;.95,-.17,;1.85,-1.42,;.95,-2.66,;-.52,-2.19,;-1.85,-2.96,;-3.19,-2.19,;-4.52,-2.96,;-3.19,-.65,;-4.52,.12,;2.94,-2.5,;4.47,-2.29,;5.14,-3.67,;4.03,-4.74,;2.67,-4.02,;3.19,-.65,;4.52,-1.42,;5.85,-.65,;5.85,.89,;4.52,1.66,;3.19,.89,)|	InChI=1S/C26H24ClF2N3O3/c1-30-24(33)16-13-32-25(34-2)23(29)21(16)20-15-12-26(19-9-6-10-31-19,14-7-4-3-5-8-14)35-18(15)11-17(28)22(20)27/h3-5,7-8,11,13,19,31H,6,9-10,12H2,1-2H3,(H,30,33)	WPLRUOCMZSKESY-UHFFFAOYSA-N	695459	US12083101, Example 175	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 4.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695459	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695459&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1444241	COc1ncc(C(N)=O)c(c1F)-c1c2[C@H](C)[C@](CN)(Oc2cc(F)c1Cl)c1ccccc1 |r,wD:16.17,14.15,(-5.68,3.62,;-4.35,4.39,;-3.02,3.62,;-1.68,4.39,;-.35,3.62,;-.35,2.08,;1.19,2.08,;1.96,3.42,;2.28,1,;-1.68,1.31,;-3.02,2.08,;-4.35,1.31,;-1.68,-.23,;-.35,-1,;1.11,-.52,;1.11,1.02,;2.02,-1.77,;3.11,-2.85,;3.11,-4.39,;1.11,-3.01,;-.35,-2.54,;-1.68,-3.31,;-3.02,-2.54,;-4.35,-3.31,;-3.02,-1,;-4.35,-.23,;3.11,-.68,;4.6,-1.08,;5.68,.01,;5.29,1.5,;3.8,1.9,;2.71,.81,)|	InChI=1S/C23H20ClF2N3O3/c1-11-16-15(32-23(11,10-27)12-6-4-3-5-7-12)8-14(25)19(24)18(16)17-13(21(28)30)9-29-22(31-2)20(17)26/h3-9,11H,10,27H2,1-2H3,(H2,28,30)	GHPVTKSDQHHWNK-UHFFFAOYSA-N	695460	US12083101, Example 176	Tafazzin/Transcriptional enhancer factor TEF-3 [217-434]/Transcriptional coactivator YAP1 [60-100]	Homo sapiens		 3.00							US Patent		10.7270/Q2N87G89		aid2060365	US12083101	Bordas, V; Brocklehurst, C; Chene, P; Furet, P; Guagnano, V; Imbach-Weese, P; Kallen, J; Le Douget, M; Lorthiois, EL; McKenna, J; Salem, B; Schmelzle, T; Sellner, H; Soldermann, N; Voegtle, M; Wartmann, M	9/10/2024	1/6/2025	Novartis	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=695460	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=417&target=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=695460&enzyme=Tafazzin%2FTranscriptional+enhancer+factor+TEF-3+%5B217-434%5D%2FTranscriptional+coactivator+YAP1+%5B60-100%5D&column=ki&startPg=0&Increment=50&submit=Search											3	RSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE	8A8R,6GEC,6GE3,8CAA,8C17,6Q36,6Q2X,5OAQ	Transcriptional enhancer factor TEF-3	TEAD4_HUMAN	Q15561	H0Y308 Q6MZR9 Q8NEV5 Q92883 Q96BK2							DSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPE		Transcriptional coactivator YAP1	YAP1_HUMAN	P46937	B4DTY1 B7ZA01 E3WEB5 E3WEB6 E9PRV2 F5H202 K0KQ18 K0KYZ8 K0L195 K0L1G3 Q7Z574 Q8IUY9							MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTKYMNHLTVHNREVLYELIEKRGPATPLITVSNHQSCMDDPHLWGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGKVNMSSEFLRFKWGIGRLIAECHLNPIILPLWHVGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR		Tafazzin	TAZ_HUMAN	Q16635	A3KQT2 D3DWX2 Q5HY43 Q5HY44 Q5HY45 Q5HY48 Q86XQ6 Q86XQ7 Q86XQ8 Q86XQ9 Q86XR0